#category	term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
GO Process	GO:0006974	Cellular response to DNA damage stimulus	12	744	1.14	1.33e-07	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FANCM,WRN,ATR,ATRX,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0033554	Cellular response to stress	14	1572	0.88	1.43e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FANCM,WRN,ATR,TFEB,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0006281	DNA repair	9	497	1.19	1.39e-05	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FANCM,WRN,ATR,ATRX,BRCA2,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0010564	Regulation of cell cycle process	10	716	1.08	1.39e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,RB1,ARID1A,MCPH1,ATR,SMARCA4,ATRX,BRCA2,PTPN11
GO Process	GO:0031297	Replication fork processing	5	45	1.98	1.39e-05	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	FANCM,WRN,ATR,ATRX,BRCA2
GO Process	GO:0031325	Positive regulation of cellular metabolic process	16	3114	0.64	2.46e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,NTRK2,WRN,ARID1A,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0042770	Signal transduction in response to DNA damage	6	135	1.58	2.46e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,ATR,ATRX,BRCA2,PTPN11
GO Process	GO:0051173	Positive regulation of nitrogen compound metabolic process	16	3166	0.64	2.63e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0090304	Nucleic acid metabolic process	14	2203	0.74	2.63e-05	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,WRN,ATR,SMARCA4,ATRX,AR,BRCA2,PIK3R1,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0006139	Nucleobase-containing compound metabolic process	15	2722	0.67	2.86e-05	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,WRN,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0009411	Response to UV	6	150	1.53	2.86e-05	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000498881	MSH2,WRN,ATR,BRCA2,PIK3R1,ERCC5
GO Process	GO:1901987	Regulation of cell cycle phase transition	8	431	1.2	2.86e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,RB1,ARID1A,ATR,SMARCA4,BRCA2,PTPN11
GO Process	GO:0009893	Positive regulation of metabolic process	17	3847	0.58	3.00e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0051054	Positive regulation of DNA metabolic process	7	304	1.29	4.68e-05	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441	MSH2,FUS,WRN,ARID1A,ATR,SMARCA4,ATRX
GO Process	GO:0010604	Positive regulation of macromolecule metabolic process	16	3533	0.59	6.91e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0034502	Protein localization to chromosome	5	92	1.67	6.91e-05	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	MSH2,RB1,ATR,ATRX,BRCA2
GO Process	GO:0051716	Cellular response to stimulus	20	6357	0.43	7.07e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,ATR,TFEB,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0051052	Regulation of DNA metabolic process	8	541	1.1	8.68e-05	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497	MSH2,FUS,WRN,ARID1A,ATR,SMARCA4,ATRX,BRCA2
GO Process	GO:0044237	Cellular metabolic process	20	6568	0.42	0.00011	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0033044	Regulation of chromosome organization	6	253	1.31	0.00024	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441	RB1,ARID1A,MCPH1,ATR,SMARCA4,ATRX
GO Process	GO:0048608	Reproductive structure development	7	436	1.14	0.00029	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,TFEB,ATRX,AR,BRCA2,PTPN11
GO Process	GO:0010948	Negative regulation of cell cycle process	6	272	1.28	0.00031	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000489597	CDKN1B,MSH2,RB1,ATR,ATRX,PTPN11
GO Process	GO:0045935	Positive regulation of nucleobase-containing compound metabolic process	12	2056	0.7	0.00037	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	MSH2,FUS,RB1,WRN,ARID1A,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1
GO Process	GO:0051276	Chromosome organization	9	968	0.9	0.00037	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497	MSH2,RB1,FANCM,WRN,ARID1A,ATR,SMARCA4,ATRX,BRCA2
GO Process	GO:0033365	Protein localization to organelle	8	713	0.98	0.00043	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056	MSH2,RB1,WRN,MCPH1,ATR,ATRX,BRCA2,PIK3R1
GO Process	GO:0007346	Regulation of mitotic cell cycle	7	493	1.08	0.00050	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,RB1,ARID1A,SMARCA4,BRCA2,PTPN11
GO Process	GO:0010225	Response to UV-C	3	15	2.23	0.00050	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000498881	WRN,BRCA2,ERCC5
GO Process	GO:0003006	Developmental process involved in reproduction	9	1023	0.88	0.00051	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,RB1,TFEB,ROS1,ATRX,AR,BRCA2,PTPN11
GO Process	GO:0070198	Protein localization to chromosome, telomeric region	3	17	2.18	0.00063	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	ATR,ATRX,BRCA2
GO Process	GO:0048513	Animal organ development	14	3246	0.57	0.00080	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,RB1,RSPO2,NTRK2,WRN,MCPH1,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0048731	System development	15	3867	0.52	0.00094	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,RB1,RSPO2,NTRK2,WRN,ARID1A,MCPH1,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0022402	Cell cycle process	8	835	0.91	0.0011	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497	CDKN1B,MSH2,RB1,FANCM,WRN,MCPH1,ATRX,BRCA2
GO Process	GO:0022414	Reproductive process	10	1504	0.76	0.0011	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,RB1,FANCM,TFEB,ROS1,ATRX,AR,BRCA2,PTPN11
GO Process	GO:0051128	Regulation of cellular component organization	12	2365	0.64	0.0011	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,RB1,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ROS1,ATRX,AR,PIK3R1,PTPN11
GO Process	GO:0006302	Double-strand break repair	5	204	1.32	0.0012	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000498881	MSH2,FANCM,WRN,BRCA2,ERCC5
GO Process	GO:0048519	Negative regulation of biological process	17	5313	0.44	0.0012	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,RSPO2,NTRK2,MCPH1,ATR,SMARCA4,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
GO Process	GO:0045934	Negative regulation of nucleobase-containing compound metabolic process	10	1562	0.74	0.0013	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497	CDKN1B,MSH2,FUS,RB1,MCPH1,ATR,SMARCA4,ATRX,AR,BRCA2
GO Process	GO:0072331	Signal transduction by p53 class mediator	4	93	1.57	0.0013	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000362441,9606.ENSP00000369497	CDKN1B,MSH2,ATRX,BRCA2
GO Process	GO:0043069	Negative regulation of programmed cell death	8	911	0.88	0.0016	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,RB1,NTRK2,AR,PIK3R1,ERCC5,MUTYH
GO Process	GO:0048518	Positive regulation of biological process	18	6207	0.4	0.0016	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:1901988	Negative regulation of cell cycle phase transition	5	225	1.28	0.0016	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000489597	CDKN1B,MSH2,RB1,ATR,PTPN11
GO Process	GO:0007049	Cell cycle	9	1246	0.79	0.0017	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,RB1,FANCM,WRN,MCPH1,ATRX,BRCA2,PTPN11
GO Process	GO:0060255	Regulation of macromolecule metabolic process	18	6249	0.39	0.0017	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0000077	DNA damage checkpoint signaling	4	105	1.51	0.0019	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000343741,9606.ENSP00000489597	CDKN1B,MSH2,ATR,PTPN11
GO Process	GO:0006310	DNA recombination	5	235	1.26	0.0019	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000498881	MSH2,FANCM,WRN,BRCA2,ERCC5
GO Process	GO:0048522	Positive regulation of cellular process	17	5584	0.42	0.0020	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,RSPO2,NTRK2,WRN,ARID1A,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0000724	Double-strand break repair via homologous recombination	4	114	1.48	0.0024	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000498881	FANCM,WRN,BRCA2,ERCC5
GO Process	GO:0031323	Regulation of cellular metabolic process	17	5681	0.41	0.0024	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0051171	Regulation of nitrogen compound metabolic process	17	5734	0.4	0.0026	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0043170	Macromolecule metabolic process	17	5781	0.4	0.0029	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,NTRK2,WRN,ATR,SMARCA4,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0080134	Regulation of response to stress	9	1373	0.75	0.0029	9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FUS,RB1,ARID1A,MCPH1,ATR,SMARCA4,BRCA2,PIK3R1,PTPN11
GO Process	GO:0048856	Anatomical structure development	16	5117	0.43	0.0033	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,RB1,RSPO2,NTRK2,WRN,ARID1A,MCPH1,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0006807	Nitrogen compound metabolic process	18	6643	0.37	0.0034	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,NTRK2,WRN,ATR,SMARCA4,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0007548	Sex differentiation	5	282	1.18	0.0035	9606.ENSP00000233146,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	MSH2,ATRX,AR,BRCA2,PTPN11
GO Process	GO:0010605	Negative regulation of macromolecule metabolic process	12	2760	0.57	0.0035	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497	CDKN1B,MSH2,FUS,RB1,NTRK2,MCPH1,ATR,SMARCA4,ROS1,ATRX,AR,BRCA2
GO Process	GO:0031324	Negative regulation of cellular metabolic process	11	2265	0.62	0.0035	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497	CDKN1B,MSH2,FUS,RB1,NTRK2,MCPH1,ATR,SMARCA4,ATRX,AR,BRCA2
GO Process	GO:0080090	Regulation of primary metabolic process	17	5899	0.39	0.0035	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:2000779	Regulation of double-strand break repair	4	135	1.4	0.0037	9606.ENSP00000254108,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896	FUS,ARID1A,ATR,SMARCA4
GO Process	GO:0006284	Base-excision repair	3	43	1.78	0.0040	9606.ENSP00000298139,9606.ENSP00000498881,9606.ENSP00000500891	WRN,ERCC5,MUTYH
GO Process	GO:0048583	Regulation of response to stimulus	14	3931	0.48	0.0040	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,FUS,RB1,RSPO2,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ROS1,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0050680	Negative regulation of epithelial cell proliferation	4	139	1.39	0.0040	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000363822,9606.ENSP00000369497	CDKN1B,RB1,AR,BRCA2
GO Process	GO:0030330	DNA damage response, signal transduction by p53 class mediator	3	44	1.77	0.0041	9606.ENSP00000228872,9606.ENSP00000362441,9606.ENSP00000369497	CDKN1B,ATRX,BRCA2
GO Process	GO:0009628	Response to abiotic stimulus	8	1107	0.79	0.0043	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000498881	CDKN1B,MSH2,WRN,ATR,SDHD,BRCA2,PIK3R1,ERCC5
GO Process	GO:0010212	Response to ionizing radiation	4	143	1.38	0.0043	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497	MSH2,WRN,ATR,BRCA2
GO Process	GO:0043067	Regulation of programmed cell death	9	1492	0.71	0.0046	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,RB1,NTRK2,WRN,AR,PIK3R1,ERCC5,MUTYH
GO Process	GO:0010557	Positive regulation of macromolecule biosynthetic process	10	1935	0.65	0.0052	9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	FUS,RB1,ARID1A,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1
GO Process	GO:0035556	Intracellular signal transduction	9	1518	0.71	0.0052	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,RB1,ATR,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0051172	Negative regulation of nitrogen compound metabolic process	11	2403	0.59	0.0052	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497	CDKN1B,MSH2,FUS,RB1,NTRK2,MCPH1,ATR,SMARCA4,ATRX,AR,BRCA2
GO Process	GO:2001020	Regulation of response to DNA damage stimulus	5	316	1.13	0.0052	9606.ENSP00000254108,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000369497	FUS,ARID1A,ATR,SMARCA4,BRCA2
GO Process	GO:0019219	Regulation of nucleobase-containing compound metabolic process	14	4074	0.47	0.0054	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	CDKN1B,MSH2,FUS,RB1,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1
GO Process	GO:0048523	Negative regulation of cellular process	15	4736	0.43	0.0057	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,NTRK2,MCPH1,ATR,SMARCA4,ATRX,AR,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
GO Process	GO:0033043	Regulation of organelle organization	8	1190	0.76	0.0064	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000428056	CDKN1B,RB1,ARID1A,MCPH1,ATR,SMARCA4,ATRX,PIK3R1
GO Process	GO:2000045	Regulation of G1/S transition of mitotic cell cycle	4	164	1.32	0.0064	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896	CDKN1B,RB1,ARID1A,SMARCA4
GO Process	GO:0010332	Response to gamma radiation	3	55	1.67	0.0066	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497	WRN,ATR,BRCA2
GO Process	GO:2001022	Positive regulation of response to DNA damage stimulus	4	168	1.31	0.0069	9606.ENSP00000254108,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896	FUS,ARID1A,ATR,SMARCA4
GO Process	GO:0006289	Nucleotide-excision repair	3	57	1.65	0.0071	9606.ENSP00000369497,9606.ENSP00000491742,9606.ENSP00000498881	BRCA2,BIVM-ERCC5,ERCC5
GO Process	GO:0031328	Positive regulation of cellular biosynthetic process	10	2041	0.62	0.0072	9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	FUS,RB1,ARID1A,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1
GO Process	GO:0045787	Positive regulation of cell cycle	5	349	1.09	0.0072	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,RB1,ATRX,BRCA2,PTPN11
GO Process	GO:0048609	Multicellular organismal reproductive process	7	883	0.83	0.0074	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	MSH2,RB1,ROS1,ATRX,AR,BRCA2,PTPN11
GO Process	GO:0010468	Regulation of gene expression	15	4899	0.42	0.0076	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,NTRK2,ARID1A,MCPH1,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0043066	Negative regulation of apoptotic process	7	891	0.83	0.0076	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000498881	CDKN1B,MSH2,RB1,NTRK2,AR,PIK3R1,ERCC5
GO Process	GO:0044238	Primary metabolic process	18	7156	0.33	0.0076	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,NTRK2,WRN,ATR,SMARCA4,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0090398	Cellular senescence	3	60	1.63	0.0077	9606.ENSP00000228872,9606.ENSP00000298139,9606.ENSP00000369497	CDKN1B,WRN,BRCA2
GO Process	GO:0042325	Regulation of phosphorylation	8	1251	0.74	0.0080	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,RB1,NTRK2,MCPH1,ROS1,AR,PIK3R1,PTPN11
GO Process	GO:0034654	Nucleobase-containing compound biosynthetic process	7	913	0.82	0.0083	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000428056	RB1,WRN,SMARCA4,ATRX,AR,SDHD,PIK3R1
GO Process	GO:0071478	Cellular response to radiation	4	183	1.27	0.0083	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000428056	WRN,ATR,BRCA2,PIK3R1
GO Process	GO:0048584	Positive regulation of response to stimulus	10	2131	0.6	0.0091	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,FUS,RSPO2,NTRK2,ARID1A,ATR,SMARCA4,AR,PIK3R1,PTPN11
GO Process	GO:0000278	Mitotic cell cycle	6	631	0.91	0.0095	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000342924,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,RB1,MCPH1,BRCA2,PTPN11
GO Process	GO:0045893	Positive regulation of transcription, DNA-templated	9	1710	0.65	0.0100	9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	FUS,RB1,ARID1A,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1
GO Process	GO:0048468	Cell development	9	1719	0.65	0.0101	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,RB1,NTRK2,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0007399	Nervous system development	10	2188	0.59	0.0108	9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	RB1,RSPO2,NTRK2,WRN,ARID1A,MCPH1,SMARCA4,ATRX,BRCA2,PTPN11
GO Process	GO:0060768	Regulation of epithelial cell proliferation involved in prostate gland development	2	10	2.23	0.0109	9606.ENSP00000228872,9606.ENSP00000363822	CDKN1B,AR
GO Process	GO:0040008	Regulation of growth	6	671	0.88	0.0122	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000363822	CDKN1B,RB1,WRN,SMARCA4,ROS1,AR
GO Process	GO:0050789	Regulation of biological process	22	11655	0.21	0.0122	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
GO Process	GO:0007154	Cell communication	15	5165	0.4	0.0123	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,RB1,RSPO2,NTRK2,WRN,ARID1A,ATR,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0008630	Intrinsic apoptotic signaling pathway in response to DNA damage	3	75	1.53	0.0123	9606.ENSP00000233146,9606.ENSP00000369497,9606.ENSP00000428056	MSH2,BRCA2,PIK3R1
GO Process	GO:0048589	Developmental growth	5	412	1.02	0.0123	9606.ENSP00000276659,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	RSPO2,ATRX,AR,BRCA2,PTPN11
GO Process	GO:0071479	Cellular response to ionizing radiation	3	75	1.53	0.0123	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497	WRN,ATR,BRCA2
GO Process	GO:0051239	Regulation of multicellular organismal process	11	2749	0.53	0.0124	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,RB1,RSPO2,NTRK2,ARID1A,SMARCA4,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0071704	Organic substance metabolic process	18	7522	0.31	0.0126	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,NTRK2,WRN,ATR,SMARCA4,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Process	GO:0006285	Base-excision repair, AP site formation	2	12	2.15	0.0135	9606.ENSP00000498881,9606.ENSP00000500891	ERCC5,MUTYH
GO Process	GO:0007169	Transmembrane receptor protein tyrosine kinase signaling pathway	5	425	1.0	0.0135	9606.ENSP00000277120,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597	NTRK2,ROS1,AR,PIK3R1,PTPN11
GO Process	GO:0008406	Gonad development	4	226	1.18	0.0150	9606.ENSP00000233146,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497	MSH2,ATRX,AR,BRCA2
GO Process	GO:0080135	Regulation of cellular response to stress	6	712	0.86	0.0151	9606.ENSP00000254108,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000428056	FUS,ARID1A,ATR,SMARCA4,BRCA2,PIK3R1
GO Process	GO:0051130	Positive regulation of cellular component organization	7	1049	0.76	0.0156	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000428056	CDKN1B,RB1,NTRK2,ATR,ATRX,AR,PIK3R1
GO Process	GO:0035264	Multicellular organism growth	3	88	1.47	0.0170	9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000489597	ATRX,AR,PTPN11
GO Process	GO:2000781	Positive regulation of double-strand break repair	3	89	1.46	0.0175	9606.ENSP00000254108,9606.ENSP00000320485,9606.ENSP00000343896	FUS,ARID1A,SMARCA4
GO Process	GO:0042981	Regulation of apoptotic process	8	1462	0.67	0.0176	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000498881	CDKN1B,MSH2,RB1,NTRK2,WRN,AR,PIK3R1,ERCC5
GO Process	GO:0030071	Regulation of mitotic metaphase/anaphase transition	3	91	1.45	0.0182	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896	RB1,ARID1A,SMARCA4
GO Process	GO:0072520	Seminiferous tubule development	2	15	2.06	0.0183	9606.ENSP00000362441,9606.ENSP00000363822	ATRX,AR
GO Process	GO:0007276	Gamete generation	6	756	0.83	0.0195	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497	MSH2,RB1,ROS1,ATRX,AR,BRCA2
GO Process	GO:0009725	Response to hormone	6	762	0.83	0.0200	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,RB1,ARID1A,AR,PIK3R1,PTPN11
GO Process	GO:0090399	Replicative senescence	2	16	2.03	0.0200	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
GO Process	GO:0051240	Positive regulation of multicellular organismal process	8	1505	0.66	0.0203	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,RB1,NTRK2,ARID1A,SMARCA4,AR,PIK3R1,PTPN11
GO Process	GO:0000723	Telomere maintenance	3	97	1.42	0.0207	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497	WRN,ATR,BRCA2
GO Process	GO:0007420	Brain development	6	775	0.82	0.0211	9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	NTRK2,WRN,MCPH1,ATRX,BRCA2,PTPN11
GO Process	GO:0035265	Organ growth	3	98	1.42	0.0211	9606.ENSP00000276659,9606.ENSP00000363822,9606.ENSP00000489597	RSPO2,AR,PTPN11
GO Process	GO:0043549	Regulation of kinase activity	6	778	0.82	0.0211	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000357494,9606.ENSP00000428056	CDKN1B,RB1,NTRK2,MCPH1,ROS1,PIK3R1
GO Process	GO:0048009	Insulin-like growth factor receptor signaling pathway	2	17	2.0	0.0211	9606.ENSP00000363822,9606.ENSP00000428056	AR,PIK3R1
GO Process	GO:0032870	Cellular response to hormone stimulus	5	489	0.94	0.0213	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597	RB1,ARID1A,AR,PIK3R1,PTPN11
GO Process	GO:0010628	Positive regulation of gene expression	7	1146	0.72	0.0232	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,FUS,NTRK2,ARID1A,AR,PIK3R1,PTPN11
GO Process	GO:0050793	Regulation of developmental process	10	2492	0.54	0.0236	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,RB1,RSPO2,NTRK2,ARID1A,SMARCA4,AR,PIK3R1,PTPN11
GO Process	GO:0006337	Nucleosome disassembly	2	19	1.95	0.0249	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
GO Process	GO:0050794	Regulation of cellular process	21	11025	0.21	0.0259	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
GO Process	GO:0045595	Regulation of cell differentiation	8	1582	0.64	0.0261	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,RB1,NTRK2,ARID1A,SMARCA4,AR,PIK3R1,PTPN11
GO Process	GO:0006312	Mitotic recombination	2	20	1.93	0.0263	9606.ENSP00000233146,9606.ENSP00000369497	MSH2,BRCA2
GO Process	GO:0006351	Transcription, DNA-templated	5	518	0.92	0.0263	9606.ENSP00000267163,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000428056	RB1,SMARCA4,ATRX,AR,PIK3R1
GO Process	GO:0044093	Positive regulation of molecular function	8	1587	0.64	0.0263	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000363822	CDKN1B,MSH2,RB1,NTRK2,WRN,SMARCA4,ROS1,AR
GO Process	GO:0065009	Regulation of molecular function	11	3085	0.48	0.0263	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000498881	CDKN1B,MSH2,RB1,NTRK2,WRN,MCPH1,SMARCA4,ROS1,AR,PIK3R1,ERCC5
GO Process	GO:0007063	Regulation of sister chromatid cohesion	2	21	1.91	0.0283	9606.ENSP00000267163,9606.ENSP00000362441	RB1,ATRX
GO Process	GO:0030521	Androgen receptor signaling pathway	2	21	1.91	0.0283	9606.ENSP00000320485,9606.ENSP00000363822	ARID1A,AR
GO Process	GO:1903047	Mitotic cell cycle process	5	537	0.9	0.0291	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000342924,9606.ENSP00000369497	CDKN1B,MSH2,RB1,MCPH1,BRCA2
GO Process	GO:0030520	Intracellular estrogen receptor signaling pathway	2	22	1.89	0.0298	9606.ENSP00000320485,9606.ENSP00000363822	ARID1A,AR
GO Process	GO:0032501	Multicellular organismal process	16	6490	0.32	0.0302	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,RB1,RSPO2,NTRK2,WRN,ARID1A,MCPH1,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11
GO Process	GO:0140747	Regulation of ncRNA transcription	2	23	1.87	0.0320	9606.ENSP00000343896,9606.ENSP00000362441	SMARCA4,ATRX
GO Process	GO:0045931	Positive regulation of mitotic cell cycle	3	121	1.33	0.0325	9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000489597	RB1,BRCA2,PTPN11
GO Process	GO:0006338	Chromatin remodeling	4	303	1.05	0.0333	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441	RB1,ARID1A,SMARCA4,ATRX
GO Process	GO:0002684	Positive regulation of immune system process	6	874	0.77	0.0335	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,RB1,ARID1A,SMARCA4,PIK3R1,PTPN11
GO Process	GO:0033260	Nuclear DNA replication	2	24	1.85	0.0340	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
GO Process	GO:1902105	Regulation of leukocyte differentiation	4	315	1.04	0.0373	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000428056	RB1,ARID1A,SMARCA4,PIK3R1
GO Process	GO:0038179	Neurotrophin signaling pathway	2	26	1.82	0.0380	9606.ENSP00000277120,9606.ENSP00000489597	NTRK2,PTPN11
GO Process	GO:0009755	Hormone-mediated signaling pathway	3	133	1.29	0.0401	9606.ENSP00000320485,9606.ENSP00000363822,9606.ENSP00000489597	ARID1A,AR,PTPN11
GO Process	GO:0007283	Spermatogenesis	5	591	0.86	0.0408	9606.ENSP00000267163,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497	RB1,ROS1,ATRX,AR,BRCA2
GO Process	GO:0006275	Regulation of DNA replication	3	136	1.28	0.0419	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	ATR,ATRX,BRCA2
GO Process	GO:2000819	Regulation of nucleotide-excision repair	2	28	1.79	0.0422	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
GO Process	GO:0051093	Negative regulation of developmental process	6	933	0.74	0.0434	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000343896,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,RB1,RSPO2,SMARCA4,PIK3R1,PTPN11
GO Process	GO:0051251	Positive regulation of lymphocyte activation	4	336	1.01	0.0445	9606.ENSP00000233146,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000489597	MSH2,ARID1A,SMARCA4,PTPN11
GO Process	GO:0071480	Cellular response to gamma radiation	2	29	1.77	0.0445	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
GO Process	GO:0006298	Mismatch repair	2	30	1.76	0.0467	9606.ENSP00000233146,9606.ENSP00000500891	MSH2,MUTYH
GO Process	GO:0008584	Male gonad development	3	145	1.25	0.0484	9606.ENSP00000233146,9606.ENSP00000362441,9606.ENSP00000363822	MSH2,ATRX,AR
GO Process	GO:0010556	Regulation of macromolecule biosynthetic process	12	3980	0.41	0.0487	9606.ENSP00000228872,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	CDKN1B,FUS,RB1,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1
GO Process	GO:0010165	Response to X-ray	2	31	1.74	0.0489	9606.ENSP00000233146,9606.ENSP00000369497	MSH2,BRCA2
GO Function	GO:0003677	DNA binding	15	2498	0.71	2.60e-05	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,WRN,ARID1A,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,BIVM-ERCC5,ERCC5,MUTYH
GO Function	GO:0140097	Catalytic activity, acting on DNA	7	221	1.43	2.60e-05	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FANCM,WRN,SMARCA4,ATRX,ERCC5,MUTYH
GO Function	GO:0008094	ATP-dependent activity, acting on DNA	5	110	1.59	0.00027	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000362441	MSH2,FANCM,WRN,SMARCA4,ATRX
GO Function	GO:0032404	Mismatch repair complex binding	3	7	2.56	0.00027	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000500891	WRN,ATR,MUTYH
GO Function	GO:0019899	Enzyme binding	12	2084	0.69	0.00087	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,RB1,NTRK2,SMARCA4,TFEB,ROS1,AR,BRCA2,PIK3R1,PTPN11,ERCC5
GO Function	GO:0003684	Damaged DNA binding	4	69	1.7	0.0012	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,WRN,ERCC5,MUTYH
GO Function	GO:0097159	Organic cyclic compound binding	18	6050	0.41	0.0021	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,SDHD,BRCA2,BIVM-ERCC5,ERCC5,MUTYH
GO Function	GO:1901363	Heterocyclic compound binding	18	5977	0.41	0.0021	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,SDHD,BRCA2,BIVM-ERCC5,ERCC5,MUTYH
GO Function	GO:0000217	DNA secondary structure binding	3	30	1.93	0.0033	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000498881	FANCM,WRN,ERCC5
GO Function	GO:0032405	MutLalpha complex binding	2	4	2.63	0.0080	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
GO Function	GO:0004386	Helicase activity	4	149	1.36	0.0103	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000362441	FANCM,WRN,SMARCA4,ATRX
GO Function	GO:0032407	MutSalpha complex binding	2	5	2.53	0.0103	9606.ENSP00000343741,9606.ENSP00000500891	ATR,MUTYH
GO Function	GO:0009378	Four-way junction helicase activity	2	6	2.46	0.0119	9606.ENSP00000267430,9606.ENSP00000298139	FANCM,WRN
GO Function	GO:0016887	ATP hydrolysis activity	5	333	1.11	0.0119	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000362441	MSH2,FANCM,WRN,SMARCA4,ATRX
GO Function	GO:0003682	Chromatin binding	6	584	0.94	0.0133	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000363822	MSH2,FUS,FANCM,WRN,ATRX,AR
GO Function	GO:0032357	Oxidized purine DNA binding	2	7	2.39	0.0133	9606.ENSP00000298139,9606.ENSP00000500891	WRN,MUTYH
GO Function	GO:0005488	Binding	23	12838	0.19	0.0138	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Function	GO:0000405	Bubble DNA binding	2	8	2.33	0.0144	9606.ENSP00000298139,9606.ENSP00000498881	WRN,ERCC5
GO Function	GO:0003678	DNA helicase activity	3	63	1.61	0.0144	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000362441	FANCM,WRN,ATRX
GO Function	GO:0005515	Protein binding	18	7242	0.33	0.0144	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FUS,RB1,RSPO2,NTRK2,WRN,ARID1A,MCPH1,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11,ERCC5
GO Function	GO:0000400	Four-way junction DNA binding	2	10	2.23	0.0175	9606.ENSP00000267430,9606.ENSP00000298139	FANCM,WRN
GO Function	GO:0004518	Nuclease activity	4	202	1.23	0.0175	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000491742,9606.ENSP00000498881	FANCM,WRN,BIVM-ERCC5,ERCC5
GO Function	GO:0043138	3-5 DNA helicase activity	2	11	2.19	0.0191	9606.ENSP00000267430,9606.ENSP00000298139	FANCM,WRN
GO Function	GO:0030983	Mismatched DNA binding	2	14	2.09	0.0282	9606.ENSP00000233146,9606.ENSP00000500891	MSH2,MUTYH
GO Function	GO:0051219	Phosphoprotein binding	3	92	1.45	0.0315	9606.ENSP00000267163,9606.ENSP00000428056,9606.ENSP00000489597	RB1,PIK3R1,PTPN11
GO Function	GO:0005524	ATP binding	8	1491	0.66	0.0324	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441	MSH2,FANCM,NTRK2,WRN,ATR,SMARCA4,ROS1,ATRX
GO Function	GO:0003824	Catalytic activity	15	5522	0.37	0.0374	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FANCM,NTRK2,WRN,ATR,SMARCA4,ROS1,ATRX,SDHD,BRCA2,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Component	GO:0005694	Chromosome	12	1850	0.74	0.00050	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000498881	MSH2,RB1,FANCM,WRN,ARID1A,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,ERCC5
GO Component	GO:0005654	Nucleoplasm	16	4169	0.52	0.00088	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,BRCA2,PTPN11,ERCC5,MUTYH
GO Component	GO:0016514	SWI/SNF complex	3	30	1.93	0.0038	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896	RB1,ARID1A,SMARCA4
GO Component	GO:0000781	Chromosome, telomeric region	4	143	1.38	0.0083	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497	MSH2,WRN,ATRX,BRCA2
GO Component	GO:0005634	Nucleus	19	7672	0.33	0.0083	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
GO Component	GO:1990391	DNA repair complex	3	43	1.78	0.0083	9606.ENSP00000233146,9606.ENSP00000369497,9606.ENSP00000498881	MSH2,BRCA2,ERCC5
GO Component	GO:0098687	Chromosomal region	5	365	1.07	0.0147	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497	MSH2,WRN,SMARCA4,ATRX,BRCA2
GO Component	GO:0140092	bBAF complex	2	10	2.23	0.0147	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
GO Component	GO:0140513	Nuclear protein-containing complex	8	1290	0.73	0.0147	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000498881	MSH2,RB1,FANCM,ARID1A,ATR,SMARCA4,BRCA2,ERCC5
GO Component	GO:0071564	npBAF complex	2	14	2.09	0.0226	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
GO Component	GO:0032991	Protein-containing complex	15	5506	0.37	0.0252	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,RB1,FANCM,NTRK2,ARID1A,ATR,SMARCA4,ROS1,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
GO Component	GO:0071565	nBAF complex	2	16	2.03	0.0252	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
GO Component	GO:0016605	PML body	3	103	1.4	0.0266	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441	RB1,ATR,ATRX
STRING clusters	CL:6143	DNA repair pathways, full network, and HDR through Homologous Recombination (HRR)	8	156	1.64	3.88e-08	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FANCM,WRN,ATR,BRCA2,BIVM-ERCC5,ERCC5,MUTYH
STRING clusters	CL:6147	DNA repair pathways, full network, and HDR through Homologous Recombination (HRR)	7	96	1.8	4.51e-08	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000491742,9606.ENSP00000498881	MSH2,FANCM,WRN,ATR,BRCA2,BIVM-ERCC5,ERCC5
STRING clusters	CL:6148	Diseases of DNA repair, and DNA repair complex	6	76	1.83	3.12e-07	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000491742,9606.ENSP00000498881	MSH2,WRN,ATR,BRCA2,BIVM-ERCC5,ERCC5
STRING clusters	CL:6244	DNA repair complex	3	28	1.96	0.0040	9606.ENSP00000233146,9606.ENSP00000491742,9606.ENSP00000498881	MSH2,BIVM-ERCC5,ERCC5
STRING clusters	CL:6149	Homologous DNA Pairing and Strand Exchange, and Response to intra-S DNA damage checkpoint signaling	3	48	1.73	0.0159	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497	WRN,ATR,BRCA2
STRING clusters	CL:5108	npBAF complex	2	10	2.23	0.0433	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
STRING clusters	CL:6280	Nucleotide-excision repair complex, and XPG/Rad2 endonuclease, eukaryotes	2	10	2.23	0.0433	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
KEGG	hsa05220	Chronic myeloid leukemia	4	75	1.66	0.00067	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,RB1,PIK3R1,PTPN11
KEGG	hsa05215	Prostate cancer	4	97	1.55	0.00089	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000363822,9606.ENSP00000428056	CDKN1B,RB1,AR,PIK3R1
KEGG	hsa05200	Pathways in cancer	6	515	1.0	0.0025	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	CDKN1B,MSH2,RB1,AR,BRCA2,PIK3R1
KEGG	hsa03460	Fanconi anemia pathway	3	51	1.7	0.0028	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000369497	FANCM,ATR,BRCA2
KEGG	hsa05225	Hepatocellular carcinoma	4	161	1.33	0.0028	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000428056	RB1,ARID1A,SMARCA4,PIK3R1
KEGG	hsa05212	Pancreatic cancer	3	71	1.56	0.0048	9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000428056	RB1,BRCA2,PIK3R1
KEGG	hsa01522	Endocrine resistance	3	94	1.44	0.0086	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000428056	CDKN1B,RB1,PIK3R1
KEGG	hsa05222	Small cell lung cancer	3	92	1.45	0.0086	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000428056	CDKN1B,RB1,PIK3R1
KEGG	hsa04722	Neurotrophin signaling pathway	3	112	1.36	0.0117	9606.ENSP00000277120,9606.ENSP00000428056,9606.ENSP00000489597	NTRK2,PIK3R1,PTPN11
KEGG	hsa04110	Cell cycle	3	120	1.33	0.0129	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000343741	CDKN1B,RB1,ATR
KEGG	hsa05165	Human papillomavirus infection	4	324	1.02	0.0158	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000428056	CDKN1B,RB1,ATR,PIK3R1
KEGG	hsa04218	Cellular senescence	3	150	1.23	0.0188	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000428056	RB1,ATR,PIK3R1
KEGG	hsa05224	Breast cancer	3	146	1.25	0.0188	9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000428056	RB1,BRCA2,PIK3R1
KEGG	hsa05226	Gastric cancer	3	146	1.25	0.0188	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000428056	CDKN1B,RB1,PIK3R1
KEGG	hsa05203	Viral carcinogenesis	3	183	1.15	0.0285	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000428056	CDKN1B,RB1,PIK3R1
KEGG	hsa03420	Nucleotide excision repair	2	46	1.57	0.0298	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
KEGG	hsa05169	Epstein-Barr virus infection	3	192	1.13	0.0298	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000428056	CDKN1B,RB1,PIK3R1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	3	210	1.09	0.0350	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000428056	RB1,ATR,PIK3R1
KEGG	hsa04014	Ras signaling pathway	3	225	1.06	0.0403	9606.ENSP00000277120,9606.ENSP00000428056,9606.ENSP00000489597	NTRK2,PIK3R1,PTPN11
KEGG	hsa04714	Thermogenesis	3	226	1.06	0.0403	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699	ARID1A,SMARCA4,SDHD
KEGG	hsa05211	Renal cell carcinoma	2	65	1.42	0.0440	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
KEGG	hsa05223	Non-small cell lung cancer	2	68	1.4	0.0457	9606.ENSP00000267163,9606.ENSP00000428056	RB1,PIK3R1
KEGG	hsa01524	Platinum drug resistance	2	70	1.39	0.0462	9606.ENSP00000233146,9606.ENSP00000428056	MSH2,PIK3R1
KEGG	hsa05214	Glioma	2	71	1.38	0.0462	9606.ENSP00000267163,9606.ENSP00000428056	RB1,PIK3R1
KEGG	hsa05218	Melanoma	2	72	1.38	0.0462	9606.ENSP00000267163,9606.ENSP00000428056	RB1,PIK3R1
Reactome	HSA-9675135	Diseases of DNA repair	5	50	1.93	1.04e-05	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000500891	MSH2,WRN,ATR,BRCA2,MUTYH
Reactome	HSA-73894	DNA Repair	7	310	1.29	5.82e-05	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FANCM,WRN,ATR,BRCA2,ERCC5,MUTYH
Reactome	HSA-1640170	Cell Cycle	7	658	0.96	0.0034	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	CDKN1B,RB1,WRN,MCPH1,ATR,ATRX,BRCA2
Reactome	HSA-212436	Generic Transcription Pathway	9	1215	0.8	0.0034	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000489597	CDKN1B,MSH2,RB1,WRN,ARID1A,ATR,SMARCA4,AR,PTPN11
Reactome	HSA-9006115	Signaling by NTRK2 (TRKB)	3	25	2.01	0.0034	9606.ENSP00000277120,9606.ENSP00000428056,9606.ENSP00000489597	NTRK2,PIK3R1,PTPN11
Reactome	HSA-1643685	Disease	10	1702	0.7	0.0036	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000500891	CDKN1B,MSH2,RB1,WRN,ATR,ATRX,BRCA2,PIK3R1,PTPN11,MUTYH
Reactome	HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	3	39	1.82	0.0036	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497	WRN,ATR,BRCA2
Reactome	HSA-9607240	FLT3 Signaling	3	38	1.83	0.0036	9606.ENSP00000228872,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,PIK3R1,PTPN11
Reactome	HSA-9675126	Diseases of mitotic cell cycle	3	38	1.83	0.0036	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000362441	CDKN1B,RB1,ATRX
Reactome	HSA-9709570	Impaired BRCA2 binding to RAD51	3	34	1.88	0.0036	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497	WRN,ATR,BRCA2
Reactome	HSA-9028335	Activated NTRK2 signals through PI3K	2	7	2.39	0.0066	9606.ENSP00000277120,9606.ENSP00000428056	NTRK2,PIK3R1
Reactome	HSA-9028731	Activated NTRK2 signals through FRS2 and FRS3	2	11	2.19	0.0128	9606.ENSP00000277120,9606.ENSP00000489597	NTRK2,PTPN11
Reactome	HSA-9703648	Signaling by FLT3 ITD and TKD mutants	2	16	2.03	0.0236	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-180292	GAB1 signalosome	2	17	2.0	0.0251	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-210993	Tie2 Signaling	2	18	1.98	0.0251	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-2219528	PI3K/AKT Signaling in Cancer	3	105	1.39	0.0251	9606.ENSP00000228872,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,PIK3R1,PTPN11
Reactome	HSA-5654710	PI-3K cascade:FGFR3	2	18	1.98	0.0251	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-9661069	Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)	2	17	2.0	0.0251	9606.ENSP00000228872,9606.ENSP00000267163	CDKN1B,RB1
Reactome	HSA-5654720	PI-3K cascade:FGFR4	2	20	1.93	0.0260	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-5654689	PI-3K cascade:FGFR1	2	21	1.91	0.0272	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-5654695	PI-3K cascade:FGFR2	2	23	1.87	0.0294	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-1266695	Interleukin-7 signaling	2	25	1.84	0.0306	9606.ENSP00000343896,9606.ENSP00000428056	SMARCA4,PIK3R1
Reactome	HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	2	26	1.82	0.0306	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
Reactome	HSA-8940973	RUNX2 regulates osteoblast differentiation	2	24	1.85	0.0306	9606.ENSP00000267163,9606.ENSP00000363822	RB1,AR
Reactome	HSA-9701192	Defective homologous recombination repair (HRR) due to BRCA1 loss of function	2	24	1.85	0.0306	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
Reactome	HSA-9704331	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function	2	24	1.85	0.0306	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
Reactome	HSA-9704646	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function	2	24	1.85	0.0306	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
Reactome	HSA-9709603	Impaired BRCA2 binding to PALB2	2	24	1.85	0.0306	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
Reactome	HSA-186763	Downstream signal transduction	2	29	1.77	0.0315	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	2	32	1.73	0.0341	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
Reactome	HSA-9680350	Signaling by CSF1 (M-CSF) in myeloid cells	2	31	1.74	0.0341	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-3700989	Transcriptional Regulation by TP53	4	361	0.98	0.0346	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000343741	CDKN1B,MSH2,WRN,ATR
Reactome	HSA-114604	GPVI-mediated activation cascade	2	35	1.69	0.0371	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-5685938	HDR through Single Strand Annealing (SSA)	2	37	1.67	0.0397	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
Reactome	HSA-6783310	Fanconi Anemia Pathway	2	37	1.67	0.0397	9606.ENSP00000267430,9606.ENSP00000343741	FANCM,ATR
Reactome	HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	2	37	1.67	0.0397	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Reactome	HSA-8853659	RET signaling	2	41	1.62	0.0449	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-1433557	Signaling by SCF-KIT	2	43	1.6	0.0475	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Reactome	HSA-2299718	Condensation of Prophase Chromosomes	2	43	1.6	0.0475	9606.ENSP00000267163,9606.ENSP00000342924	RB1,MCPH1
Reactome	HSA-109704	PI3K Cascade	2	44	1.59	0.0481	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP2263	Androgen receptor network in prostate cancer	7	109	1.74	3.59e-08	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000489597	MSH2,RB1,ARID1A,ATR,SMARCA4,AR,PTPN11
WikiPathways	WP4946	DNA repair pathways, full network	7	120	1.7	3.59e-08	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FANCM,WRN,ATR,BRCA2,ERCC5,MUTYH
WikiPathways	WP4016	DNA IR-damage and cellular response via ATR	5	81	1.72	1.15e-05	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000369497	MSH2,WRN,MCPH1,ATR,BRCA2
WikiPathways	WP1971	Integrated cancer pathway	4	44	1.89	5.16e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000343741	CDKN1B,MSH2,RB1,ATR
WikiPathways	WP2261	Glioblastoma signaling pathways	4	82	1.62	0.00044	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000428056	CDKN1B,RB1,BRCA2,PIK3R1
WikiPathways	WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3	30	1.93	0.00096	9606.ENSP00000228872,9606.ENSP00000351742,9606.ENSP00000428056	CDKN1B,TFEB,PIK3R1
WikiPathways	WP4204	Tumor suppressor activity of SMARCB1	3	31	1.92	0.00096	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896	RB1,ARID1A,SMARCA4
WikiPathways	WP4262	Breast cancer pathway	4	154	1.35	0.0029	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000428056	RB1,ATR,BRCA2,PIK3R1
WikiPathways	WP5300	TROP2 regulatory signaling	3	49	1.72	0.0029	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000428056	CDKN1B,RB1,PIK3R1
WikiPathways	WP3959	DNA IR-double strand breaks and cellular response via ATM	3	55	1.67	0.0032	9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000369497	MCPH1,ATR,BRCA2
WikiPathways	WP1530	miRNA regulation of DNA damage response	3	71	1.56	0.0045	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000343741	CDKN1B,RB1,ATR
WikiPathways	WP2032	Thyroid stimulating hormone (TSH) signaling pathway	3	66	1.59	0.0045	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000428056	CDKN1B,RB1,PIK3R1
WikiPathways	WP2374	Oncostatin M signaling pathway	3	64	1.6	0.0045	9606.ENSP00000228872,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,PIK3R1,PTPN11
WikiPathways	WP3303	RAC1/PAK1/p38/MMP2 pathway	3	68	1.58	0.0045	9606.ENSP00000233146,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,PIK3R1,PTPN11
WikiPathways	WP707	DNA damage response	3	69	1.57	0.0045	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000343741	CDKN1B,RB1,ATR
WikiPathways	WP4263	Pancreatic adenocarcinoma pathway	3	86	1.48	0.0072	9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000428056	RB1,BRCA2,PIK3R1
WikiPathways	WP4582	Cancer immunotherapy by CTLA4 blockade	2	14	2.09	0.0072	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP138	Androgen receptor signaling pathway	3	90	1.46	0.0073	9606.ENSP00000267163,9606.ENSP00000363822,9606.ENSP00000428056	RB1,AR,PIK3R1
WikiPathways	WP4658	Small cell lung cancer	3	95	1.43	0.0081	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000428056	CDKN1B,RB1,PIK3R1
WikiPathways	WP2431	Spinal cord injury	3	115	1.35	0.0126	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000357494	CDKN1B,RB1,ROS1
WikiPathways	WP4659	Gastrin signaling pathway	3	113	1.36	0.0126	9606.ENSP00000228872,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,PIK3R1,PTPN11
WikiPathways	WP179	Cell cycle	3	120	1.33	0.0136	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000343741	CDKN1B,RB1,ATR
WikiPathways	WP205	IL-7 signaling pathway	2	25	1.84	0.0152	9606.ENSP00000228872,9606.ENSP00000428056	CDKN1B,PIK3R1
WikiPathways	WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	3	143	1.25	0.0205	9606.ENSP00000277120,9606.ENSP00000428056,9606.ENSP00000489597	NTRK2,PIK3R1,PTPN11
WikiPathways	WP3981	miRNA regulation of prostate cancer signaling pathways	2	31	1.74	0.0210	9606.ENSP00000228872,9606.ENSP00000363822	CDKN1B,AR
WikiPathways	WP244	Alpha 6 beta 4 signaling pathway	2	33	1.72	0.0227	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2	38	1.65	0.0286	9606.ENSP00000277120,9606.ENSP00000428056	NTRK2,PIK3R1
WikiPathways	WP127	IL-5 signaling pathway	2	40	1.63	0.0289	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP2526	PDGF pathway	2	40	1.63	0.0289	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP2828	Bladder cancer	2	39	1.64	0.0289	9606.ENSP00000267163,9606.ENSP00000428056	RB1,PIK3R1
WikiPathways	WP5316	Primary ovarian insufficiency	3	171	1.18	0.0289	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000369497	FANCM,WRN,BRCA2
WikiPathways	WP2332	Interleukin-11 signaling pathway	2	44	1.59	0.0292	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP364	IL6 signaling pathway	2	43	1.6	0.0292	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP4223	Ras signaling	3	181	1.15	0.0292	9606.ENSP00000277120,9606.ENSP00000428056,9606.ENSP00000489597	NTRK2,PIK3R1,PTPN11
WikiPathways	WP49	IL-2 signaling pathway	2	42	1.61	0.0292	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP2586	Aryl hydrocarbon receptor pathway	2	45	1.58	0.0296	9606.ENSP00000228872,9606.ENSP00000267163	CDKN1B,RB1
WikiPathways	WP286	IL-3 signaling pathway	2	49	1.54	0.0338	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP4539	Synaptic signaling pathways associated with autism spectrum disorder	2	50	1.53	0.0342	9606.ENSP00000277120,9606.ENSP00000428056	NTRK2,PIK3R1
WikiPathways	WP195	IL-1 signaling pathway	2	55	1.49	0.0386	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP395	IL-4 signaling pathway	2	54	1.5	0.0386	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP585	Interferon type I signaling pathways	2	54	1.5	0.0386	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP4205	MET in type 1 papillary renal cell carcinoma	2	58	1.47	0.0411	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP304	Kit receptor signaling pathway	2	59	1.46	0.0415	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
WikiPathways	WP5072	Modulators of TCR signaling and T cell activation	2	61	1.45	0.0432	9606.ENSP00000228872,9606.ENSP00000428056	CDKN1B,PIK3R1
WikiPathways	WP45	G1 to S cell cycle control	2	64	1.43	0.0463	9606.ENSP00000228872,9606.ENSP00000267163	CDKN1B,RB1
WikiPathways	WP3651	Pathways affected in adenoid cystic carcinoma	2	65	1.42	0.0466	9606.ENSP00000320485,9606.ENSP00000362441	ARID1A,ATRX
WikiPathways	WP4685	Melanoma	2	68	1.4	0.0498	9606.ENSP00000267163,9606.ENSP00000428056	RB1,PIK3R1
Monarch	HP:0011793	Neoplasm by anatomical site	16	732	1.27	3.66e-14	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,RB1,FANCM,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
Monarch	HP:0000079	Abnormality of the urinary system	17	1657	0.94	1.09e-10	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,FANCM,RSPO2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PTPN11,ERCC5,MUTYH
Monarch	HP:0000153	Abnormality of the mouth	18	1992	0.89	1.09e-10	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0002011	Morphological central nervous system abnormality	19	2416	0.83	1.09e-10	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0012639	Abnormal nervous system morphology	19	2546	0.81	1.48e-10	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000119	Abnormality of the genitourinary system	18	2189	0.85	2.40e-10	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PTPN11,ERCC5,MUTYH
Monarch	HP:0011792	Neoplasm by histology	10	275	1.49	5.02e-10	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,RB1,WRN,ARID1A,SMARCA4,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0004325	Decreased body weight	15	1274	1.0	6.34e-10	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0011024	Abnormality of the gastrointestinal tract	15	1384	0.97	1.88e-09	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000500891	CDKN1B,MSH2,FUS,FANCM,RSPO2,NTRK2,WRN,ARID1A,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,MUTYH
Monarch	HP:0012243	Abnormal reproductive system morphology	14	1117	1.03	2.14e-09	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FANCM,RSPO2,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0001824	Weight loss	9	218	1.55	2.19e-09	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000498881	MSH2,FUS,RB1,FANCM,ATR,SDHD,BRCA2,PIK3R1,ERCC5
Monarch	HP:0011842	Abnormal skeletal morphology	18	2573	0.78	2.19e-09	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0001507	Growth abnormality	17	2182	0.82	2.73e-09	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0033127	Abnormality of the musculoskeletal system	19	3173	0.71	3.12e-09	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000032	Abnormality of male external genitalia	13	933	1.08	3.45e-09	9606.ENSP00000228872,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,FANCM,RSPO2,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0012443	Abnormality of brain morphology	17	2254	0.81	3.60e-09	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,ERCC5
Monarch	HP:0000163	Abnormal oral cavity morphology	16	1901	0.86	4.16e-09	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000002	Abnormality of body height	14	1253	0.98	4.39e-09	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0003549	Abnormality of connective tissue	14	1294	0.97	6.39e-09	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000498881	CDKN1B,MSH2,FUS,FANCM,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,ERCC5
Monarch	HP:0025031	Abnormality of the digestive system	17	2389	0.78	6.39e-09	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,FANCM,RSPO2,NTRK2,WRN,ARID1A,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
Monarch	HP:0000035	Abnormal testis morphology	12	793	1.11	7.17e-09	9606.ENSP00000228872,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,FANCM,RSPO2,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,BRCA2,PTPN11,ERCC5
Monarch	HP:0010460	Abnormality of the female genitalia	10	422	1.31	8.01e-09	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,FANCM,RSPO2,WRN,ATR,AR,SDHD,BRCA2,PTPN11
Monarch	HP:0012252	Abnormal respiratory system morphology	13	1067	1.02	9.40e-09	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,FUS,RB1,FANCM,RSPO2,WRN,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11
Monarch	HP:0000818	Abnormality of the endocrine system	13	1070	1.02	9.43e-09	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FANCM,WRN,ARID1A,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0010936	Abnormality of the lower urinary tract	11	652	1.16	1.81e-08	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	FUS,FANCM,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PTPN11
Monarch	HP:0004322	Short stature	13	1152	0.99	2.16e-08	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0009121	Abnormal axial skeleton morphology	16	2206	0.79	2.32e-08	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FUS,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0001510	Growth delay	14	1525	0.9	3.83e-08	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0007378	Neoplasm of the gastrointestinal tract	8	221	1.49	3.83e-08	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000500891	CDKN1B,MSH2,WRN,ARID1A,SMARCA4,SDHD,BRCA2,MUTYH
Monarch	HP:0000008	Abnormal morphology of female internal genitalia	9	355	1.34	4.36e-08	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,FANCM,RSPO2,WRN,AR,SDHD,BRCA2,PTPN11
Monarch	HP:0100031	Neoplasm of the thyroid gland	6	69	1.87	6.87e-08	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699	CDKN1B,MSH2,WRN,ARID1A,SMARCA4,SDHD
Monarch	HP:0000478	Abnormality of the eye	17	2876	0.7	7.63e-08	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
Monarch	HP:0007364	Aplasia/Hypoplasia of the cerebrum	13	1300	0.93	8.06e-08	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	MSH2,FUS,FANCM,RSPO2,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,ERCC5
Monarch	HP:0040064	Abnormality of limbs	15	2018	0.8	8.94e-08	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000812	Abnormal internal genitalia	9	391	1.29	8.95e-08	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,FANCM,RSPO2,WRN,AR,SDHD,BRCA2,PTPN11
Monarch	HP:0000036	Abnormal penis morphology	10	592	1.16	1.35e-07	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,RSPO2,ARID1A,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PTPN11
Monarch	HP:0000077	Abnormality of the kidney	12	1077	0.98	1.48e-07	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,FANCM,RSPO2,WRN,ARID1A,MCPH1,SMARCA4,ATRX,SDHD,BRCA2,PTPN11
Monarch	HP:0010935	Abnormality of the upper urinary tract	12	1101	0.97	1.86e-07	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,FANCM,RSPO2,WRN,ARID1A,MCPH1,SMARCA4,ATRX,SDHD,BRCA2,PTPN11
Monarch	HP:0000028	Cryptorchidism	10	619	1.14	1.95e-07	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,ARID1A,ATR,SMARCA4,ATRX,AR,BRCA2,PTPN11,ERCC5
Monarch	HP:0000047	Hypospadias	8	290	1.37	2.38e-07	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ARID1A,ATR,SMARCA4,ATRX,AR,BRCA2,PTPN11
Monarch	HP:0007379	Neoplasm of the genitourinary tract	7	179	1.52	3.00e-07	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497	CDKN1B,MSH2,RB1,WRN,AR,SDHD,BRCA2
Monarch	HP:0000118	Phenotypic abnormality	20	5129	0.52	3.52e-07	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
Monarch	HP:0001511	Intrauterine growth retardation	9	469	1.22	3.53e-07	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,ARID1A,ATR,SMARCA4,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0001574	Abnormality of the integument	15	2266	0.75	3.59e-07	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FANCM,NTRK2,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000290	Abnormality of the forehead	11	926	1.01	4.37e-07	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0011446	Abnormality of higher mental function	15	2301	0.75	4.37e-07	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0030669	Abnormal ocular adnexa morphology	12	1218	0.93	4.67e-07	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0011844	Abnormal appendicular skeleton morphology	13	1557	0.85	5.18e-07	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	RB1,FANCM,RSPO2,WRN,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0031093	Abnormal breast morphology	8	332	1.31	5.36e-07	9606.ENSP00000233146,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	MSH2,RSPO2,WRN,ATR,AR,SDHD,BRCA2,PTPN11
Monarch	HP:0000929	Abnormal skull morphology	14	1954	0.79	5.88e-07	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FUS,FANCM,RSPO2,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0010786	Urinary tract neoplasm	6	110	1.67	6.16e-07	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000369497	CDKN1B,MSH2,RB1,WRN,SDHD,BRCA2
Monarch	HP:0012733	Macule	7	210	1.46	6.71e-07	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FANCM,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0009115	Aplasia/hypoplasia involving the skeleton	11	985	0.98	6.95e-07	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,WRN,ARID1A,ATR,SMARCA4,ATRX,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0001626	Abnormality of the cardiovascular system	15	2438	0.72	7.89e-07	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,RB1,FANCM,RSPO2,WRN,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0010787	Genital neoplasm	6	118	1.64	8.34e-07	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497	CDKN1B,MSH2,WRN,AR,SDHD,BRCA2
Monarch	HP:0002597	Abnormality of the vasculature	13	1673	0.82	1.01e-06	9606.ENSP00000228872,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,FANCM,RSPO2,WRN,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0011843	Abnormal musculoskeletal physiology	12	1330	0.89	1.01e-06	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,RB1,WRN,ARID1A,ATR,SMARCA4,ATRX,SDHD,PIK3R1,PTPN11,ERCC5
Monarch	HP:0003002	Breast carcinoma	5	54	1.9	1.02e-06	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000364699,9606.ENSP00000369497	MSH2,WRN,ATR,SDHD,BRCA2
Monarch	HP:0002715	Abnormality of the immune system	13	1682	0.82	1.04e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,RB1,FANCM,ARID1A,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0004377	Hematological neoplasm	7	232	1.41	1.11e-06	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,RB1,FANCM,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0000492	Abnormal eyelid morphology	11	1058	0.95	1.26e-06	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0011729	Abnormality of joint mobility	11	1063	0.95	1.30e-06	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,WRN,ARID1A,ATR,SMARCA4,ATRX,SDHD,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000252	Microcephaly	11	1080	0.94	1.50e-06	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	FUS,FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,ERCC5
Monarch	HP:0002087	Abnormality of the upper respiratory tract	8	398	1.24	1.60e-06	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000428056	MSH2,FUS,RSPO2,WRN,ARID1A,SMARCA4,ATRX,PIK3R1
Monarch	HP:0002861	Melanoma	5	61	1.85	1.60e-06	9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	WRN,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0040195	Decreased head circumference	11	1088	0.94	1.60e-06	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	FUS,FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,ERCC5
Monarch	HP:0001939	Abnormality of metabolism/homeostasis	14	2168	0.74	1.68e-06	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,RB1,FANCM,WRN,MCPH1,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
Monarch	HP:0001909	Leukemia	6	141	1.56	1.89e-06	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,RB1,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0004375	Neoplasm of the nervous system	6	142	1.56	1.92e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000489597	CDKN1B,MSH2,RB1,WRN,SDHD,PTPN11
Monarch	HP:0100242	Sarcoma	6	144	1.55	2.06e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000489597	CDKN1B,MSH2,RB1,WRN,SDHD,PTPN11
Monarch	HP:0002813	Abnormality of limb bone morphology	12	1459	0.85	2.25e-06	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	RB1,FANCM,WRN,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0002750	Delayed skeletal maturation	7	280	1.33	3.18e-06	9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	ARID1A,ATR,SMARCA4,ATRX,PIK3R1,PTPN11,ERCC5
Monarch	HP:0030084	Clinodactyly	8	443	1.19	3.18e-06	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FANCM,ARID1A,ATR,SMARCA4,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0000951	Abnormality of the skin	13	1888	0.77	3.29e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FANCM,NTRK2,WRN,ATR,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0001367	Abnormal joint morphology	10	905	0.98	3.50e-06	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	RB1,FANCM,WRN,ATR,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0012759	Neurodevelopmental abnormality	14	2323	0.71	3.55e-06	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0100543	Cognitive impairment	13	1903	0.77	3.55e-06	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0011805	Abnormal skeletal muscle morphology	12	1537	0.83	3.70e-06	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,NTRK2,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,SDHD,PTPN11,ERCC5
Monarch	HP:0010785	Gonadal neoplasm	5	76	1.75	3.80e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000369497	CDKN1B,MSH2,WRN,AR,BRCA2
Monarch	HP:0012758	Neurodevelopmental delay	13	1926	0.76	3.94e-06	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FUS,FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000137	Abnormality of the ovary	6	165	1.49	3.96e-06	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	MSH2,WRN,AR,SDHD,BRCA2,PTPN11
Monarch	HP:0001263	Global developmental delay	12	1559	0.82	4.17e-06	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FUS,FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0001508	Failure to thrive	10	949	0.96	5.06e-06	9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	NTRK2,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0012373	Abnormal eye physiology	14	2405	0.7	5.16e-06	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,RB1,FANCM,NTRK2,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000925	Abnormality of the vertebral column	11	1252	0.88	5.17e-06	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FUS,FANCM,RSPO2,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0008069	Neoplasm of the skin	6	175	1.47	5.31e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000498881	CDKN1B,MSH2,WRN,SDHD,PIK3R1,ERCC5
Monarch	HP:0001999	Abnormal facial shape	10	978	0.94	6.47e-06	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FANCM,NTRK2,WRN,ARID1A,ATR,SMARCA4,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0011121	Abnormality of skin morphology	12	1648	0.79	7.31e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FANCM,NTRK2,WRN,ATR,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000927	Abnormality of skeletal maturation	7	327	1.26	7.73e-06	9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	ARID1A,ATR,SMARCA4,ATRX,PIK3R1,PTPN11,ERCC5
Monarch	HP:0001155	Abnormality of the hand	11	1312	0.86	7.97e-06	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,WRN,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0011355	Localized skin lesion	9	738	1.02	8.09e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FANCM,WRN,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0012372	Abnormal eye morphology	13	2077	0.73	8.71e-06	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	RB1,FANCM,RSPO2,NTRK2,WRN,ATR,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
Monarch	HP:0001034	Hypermelanotic macule	6	194	1.42	9.05e-06	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FANCM,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0000130	Abnormality of the uterus	6	195	1.42	9.16e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497	CDKN1B,MSH2,FANCM,AR,SDHD,BRCA2
Monarch	HP:0000135	Hypogonadism	7	343	1.24	1.00e-05	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,WRN,ATRX,AR,BRCA2,PTPN11,ERCC5
Monarch	HP:0002167	Neurological speech impairment	11	1354	0.84	1.04e-05	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,NTRK2,ARID1A,SMARCA4,ATRX,AR,SDHD,PIK3R1,PTPN11,ERCC5
Monarch	HP:0009726	Renal neoplasm	5	98	1.64	1.08e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000369497	CDKN1B,MSH2,WRN,SDHD,BRCA2
Monarch	HP:0002012	Abnormality of the abdominal organs	10	1068	0.9	1.33e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FANCM,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11
Monarch	HP:0033353	Abnormal blood vessel morphology	9	792	0.99	1.36e-05	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,WRN,ARID1A,SMARCA4,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0001671	Abnormal cardiac septum morphology	8	556	1.09	1.37e-05	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,RSPO2,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PTPN11
Monarch	HP:0025032	Abnormality of digestive system physiology	12	1763	0.77	1.37e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FUS,NTRK2,ARID1A,SMARCA4,ATRX,AR,SDHD,PIK3R1,PTPN11,ERCC5
Monarch	HP:0011458	Abdominal symptom	11	1448	0.81	1.92e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FUS,NTRK2,ARID1A,SMARCA4,ATRX,SDHD,PIK3R1,PTPN11,ERCC5
Monarch	HP:0012210	Abnormal renal morphology	9	837	0.96	2.07e-05	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,RSPO2,ARID1A,MCPH1,SMARCA4,ATRX,SDHD,BRCA2,PTPN11
Monarch	HP:0000366	Abnormality of the nose	11	1470	0.81	2.18e-05	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,WRN,ARID1A,ATR,SMARCA4,ATRX,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0012718	Morphological abnormality of the gastrointestinal tract	9	845	0.96	2.19e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000500891	CDKN1B,MSH2,FANCM,RSPO2,ATRX,SDHD,BRCA2,PIK3R1,MUTYH
Monarch	HP:0025033	Abnormality of digestive system morphology	9	849	0.96	2.26e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000500891	CDKN1B,MSH2,FANCM,RSPO2,ATRX,SDHD,BRCA2,PIK3R1,MUTYH
Monarch	HP:0004207	Abnormal 5th finger morphology	7	396	1.18	2.32e-05	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ARID1A,ATR,SMARCA4,ATRX,BRCA2,PTPN11
Monarch	HP:0000496	Abnormality of eye movement	11	1491	0.8	2.45e-05	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FUS,FANCM,NTRK2,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0009815	Aplasia/hypoplasia of the extremities	8	614	1.05	2.65e-05	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,RSPO2,WRN,ARID1A,ATR,SMARCA4,BRCA2,PIK3R1
Monarch	HP:0005922	Abnormal hand morphology	9	870	0.95	2.70e-05	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FANCM,WRN,ARID1A,ATR,SMARCA4,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0001392	Abnormality of the liver	9	895	0.94	3.40e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,FANCM,ARID1A,SMARCA4,SDHD,BRCA2,PIK3R1,PTPN11
Monarch	HP:0100006	Neoplasm of the central nervous system	5	128	1.52	3.40e-05	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000489597	MSH2,RB1,WRN,SDHD,PTPN11
Monarch	HP:0025142	Constitutional symptom	9	906	0.93	3.71e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FUS,RB1,ATRX,SDHD,PIK3R1,PTPN11,ERCC5
Monarch	HP:0002650	Scoliosis	9	908	0.93	3.75e-05	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	FUS,FANCM,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PTPN11
Monarch	HP:0000508	Ptosis	8	647	1.02	3.76e-05	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,NTRK2,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PTPN11
Monarch	HP:0012378	Fatigue	6	258	1.3	3.79e-05	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000498881	MSH2,FUS,ATRX,SDHD,PIK3R1,ERCC5
Monarch	HP:0011276	Vascular skin abnormality	7	433	1.14	3.92e-05	9606.ENSP00000228872,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,WRN,ATR,ATRX,SDHD,PTPN11,ERCC5
Monarch	HP:0100790	Hernia	7	435	1.14	4.01e-05	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,ARID1A,SMARCA4,ATRX,AR,BRCA2,PIK3R1
Monarch	HP:0002890	Thyroid carcinoma	4	52	1.82	4.06e-05	9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699	WRN,ARID1A,SMARCA4,SDHD
Monarch	HP:0000347	Micrognathia	8	659	1.02	4.17e-05	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,ATR,ATRX,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0009118	Aplasia/Hypoplasia of the mandible	8	660	1.02	4.19e-05	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,ATR,ATRX,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0007495	Prematurely aged appearance	5	136	1.5	4.24e-05	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	WRN,ATR,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000549	Abnormal conjugate eye movement	9	934	0.92	4.47e-05	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FUS,FANCM,ARID1A,ATR,SMARCA4,ATRX,BRCA2,PTPN11,ERCC5
Monarch	HP:0000957	Cafe-au-lait spot	5	138	1.49	4.48e-05	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	MSH2,FANCM,SDHD,BRCA2,PTPN11
Monarch	HP:0011297	Abnormal digit morphology	10	1263	0.83	4.99e-05	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0012732	Anorectal anomaly	6	274	1.27	4.99e-05	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000500891	MSH2,FANCM,RSPO2,SDHD,BRCA2,MUTYH
Monarch	HP:0001274	Agenesis of corpus callosum	6	275	1.27	5.04e-05	9606.ENSP00000233146,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441	MSH2,RSPO2,ARID1A,MCPH1,SMARCA4,ATRX
Monarch	HP:0011362	Abnormal hair quantity	8	682	1.0	5.09e-05	9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	WRN,ARID1A,ATR,SMARCA4,AR,PIK3R1,PTPN11,ERCC5
Monarch	HP:0100542	Abnormal localization of kidney	5	144	1.47	5.29e-05	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ARID1A,SMARCA4,BRCA2,PTPN11
Monarch	HP:0010468	Aplasia/Hypoplasia of the testes	5	146	1.47	5.62e-05	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000498881	FANCM,WRN,ATRX,BRCA2,ERCC5
Monarch	HP:0001249	Intellectual disability	11	1656	0.76	5.96e-05	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0001167	Abnormality of finger	9	980	0.9	6.22e-05	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,ARID1A,ATR,SMARCA4,ATRX,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0007565	Multiple cafe-au-lait spots	4	60	1.76	6.30e-05	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000364699,9606.ENSP00000369497	MSH2,FANCM,SDHD,BRCA2
Monarch	HP:0002898	Embryonal neoplasm	4	61	1.75	6.67e-05	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497	RB1,ARID1A,SMARCA4,BRCA2
Monarch	HP:0030680	Abnormality of cardiovascular system morphology	11	1680	0.75	6.67e-05	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FANCM,RSPO2,WRN,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0000505	Visual impairment	9	995	0.89	6.88e-05	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	MSH2,FANCM,NTRK2,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,ERCC5
Monarch	HP:0003712	Skeletal muscle hypertrophy	5	154	1.44	6.90e-05	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699	ARID1A,SMARCA4,ATRX,AR,SDHD
Monarch	HP:0031703	Abnormal ear morphology	10	1320	0.81	6.90e-05	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,ARID1A,ATR,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0008070	Sparse hair	6	300	1.23	7.62e-05	9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000428056	WRN,ARID1A,ATR,SMARCA4,AR,PIK3R1
Monarch	HP:0000377	Abnormal pinna morphology	9	1019	0.88	8.11e-05	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,ARID1A,ATR,ATRX,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0010978	Abnormality of immune system physiology	10	1347	0.8	8.11e-05	9606.ENSP00000228872,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000498881	CDKN1B,FANCM,ARID1A,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,ERCC5
Monarch	HP:0000174	Abnormal palate morphology	9	1035	0.87	9.00e-05	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	RB1,FANCM,ATR,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0006496	Aplasia/hypoplasia involving bones of the upper limbs	7	511	1.07	9.55e-05	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,WRN,ARID1A,ATR,SMARCA4,BRCA2,PIK3R1
Monarch	HP:0031826	Abnormal reflex	9	1046	0.87	9.66e-05	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	FUS,FANCM,NTRK2,MCPH1,ATRX,AR,SDHD,BRCA2,ERCC5
Monarch	HP:0001881	Abnormal leukocyte morphology	7	517	1.06	0.00010	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,RB1,FANCM,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0010987	Abnormal cellular immune system morphology	7	517	1.06	0.00010	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,RB1,FANCM,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0001010	Hypopigmentation of the skin	5	174	1.39	0.00011	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	MSH2,FANCM,SDHD,BRCA2,ERCC5
Monarch	HP:0011927	Short digit	7	529	1.05	0.00012	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11
Monarch	HP:0012531	Pain	7	539	1.05	0.00013	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000364699,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FUS,RB1,SDHD,PTPN11,ERCC5
Monarch	HP:0001713	Abnormal cardiac ventricle morphology	7	547	1.04	0.00014	9606.ENSP00000233146,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000489597	MSH2,RSPO2,ARID1A,SMARCA4,ATRX,SDHD,PTPN11
Monarch	HP:0010938	Abnormal external nose morphology	8	816	0.92	0.00016	9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	WRN,ARID1A,ATR,SMARCA4,ATRX,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000164	Abnormality of the dentition	8	821	0.92	0.00017	9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	NTRK2,ARID1A,ATR,SMARCA4,ATRX,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000525	Abnormality iris morphology	6	352	1.16	0.00017	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056	RB1,FANCM,RSPO2,SDHD,BRCA2,PIK3R1
Monarch	HP:0001631	Atrial septal defect	6	353	1.16	0.00017	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ARID1A,SMARCA4,SDHD,BRCA2,PTPN11
Monarch	HP:0010622	Neoplasm of the skeletal system	4	81	1.63	0.00017	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000489597	MSH2,RB1,WRN,PTPN11
Monarch	HP:0011354	Generalized abnormality of skin	8	821	0.92	0.00017	9606.ENSP00000228872,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,WRN,ATR,ATRX,SDHD,PIK3R1,PTPN11,ERCC5
Monarch	EFO:0003765	Sign or symptom	7	573	1.02	0.00018	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000498881	CDKN1B,MSH2,FUS,ATRX,SDHD,PIK3R1,ERCC5
Monarch	HP:0030962	Abnormal morphology of the great vessels	7	571	1.02	0.00018	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,RSPO2,WRN,ARID1A,SMARCA4,BRCA2,PTPN11
Monarch	HP:0010615	Angiofibromas	3	22	2.07	0.00019	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000364699	CDKN1B,MSH2,SDHD
Monarch	HP:0000598	Abnormality of the ear	11	1919	0.69	0.00020	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,ARID1A,ATR,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0008056	Aplasia/Hypoplasia affecting the eye	6	367	1.15	0.00020	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000498881	FANCM,RSPO2,SDHD,BRCA2,PIK3R1,ERCC5
Monarch	HP:0011138	Abnormality of skin adnexa morphology	9	1165	0.82	0.00021	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,WRN,ARID1A,ATR,SMARCA4,AR,PIK3R1,PTPN11,ERCC5
Monarch	HP:0030236	Abnormality of muscle size	7	594	1.0	0.00022	9606.ENSP00000254108,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699	FUS,WRN,ARID1A,SMARCA4,ATRX,AR,SDHD
Monarch	HP:0200006	Slanting of the palpebral fissure	7	599	1.0	0.00023	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,NTRK2,MCPH1,ATR,ATRX,BRCA2,PTPN11
Monarch	HP:0004097	Deviation of finger	6	384	1.13	0.00025	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FANCM,ATR,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0000539	Abnormality of refraction	8	888	0.89	0.00027	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FANCM,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11
Monarch	HP:0001627	Abnormal heart morphology	9	1206	0.81	0.00027	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	MSH2,FANCM,RSPO2,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PTPN11
Monarch	HP:0001871	Abnormality of blood and blood-forming tissues	9	1214	0.8	0.00028	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,RB1,FANCM,ATR,ATRX,SDHD,BRCA2,PIK3R1,PTPN11
Monarch	HP:0002088	Abnormal lung morphology	8	893	0.88	0.00028	9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597	RB1,RSPO2,WRN,ARID1A,SMARCA4,SDHD,PIK3R1,PTPN11
Monarch	HP:0000178	Abnormal lower lip morphology	5	220	1.29	0.00029	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000489597,9606.ENSP00000498881	ARID1A,SMARCA4,ATRX,PTPN11,ERCC5
Monarch	HP:0008053	Aplasia/Hypoplasia of the iris	4	96	1.55	0.00029	9606.ENSP00000267430,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,SDHD,BRCA2,PIK3R1
Monarch	HP:0000486	Strabismus	8	903	0.88	0.00030	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,ARID1A,ATR,SMARCA4,ATRX,BRCA2,PTPN11,ERCC5
Monarch	HP:0011004	Abnormal systemic arterial morphology	6	398	1.11	0.00030	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,WRN,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0002863	Myelodysplasia	4	98	1.54	0.00031	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ATRX,BRCA2,PTPN11
Monarch	HP:0000218	High palate	7	635	0.98	0.00032	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FANCM,ATR,ATRX,SDHD,BRCA2,PIK3R1,PTPN11
Monarch	HP:0002209	Sparse scalp hair	4	100	1.53	0.00033	9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896	WRN,ARID1A,ATR,SMARCA4
Monarch	HP:0003330	Abnormal bone structure	7	639	0.97	0.00033	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000364699,9606.ENSP00000369497	RB1,FANCM,RSPO2,WRN,MCPH1,SDHD,BRCA2
Monarch	HP:0005105	Abnormal nasal morphology	9	1245	0.79	0.00033	9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	RSPO2,WRN,ARID1A,ATR,SMARCA4,ATRX,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000518	Cataract	7	642	0.97	0.00034	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000498881	FANCM,RSPO2,WRN,SDHD,BRCA2,PIK3R1,ERCC5
Monarch	HP:0001053	Hypopigmented skin patches	4	102	1.53	0.00034	9606.ENSP00000267430,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	FANCM,SDHD,BRCA2,ERCC5
Monarch	HP:0001347	Hyperreflexia	7	645	0.97	0.00034	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497	FUS,FANCM,NTRK2,MCPH1,ATRX,SDHD,BRCA2
Monarch	HP:0040069	Abnormal lower limb bone morphology	7	648	0.97	0.00035	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000498881	RB1,FANCM,WRN,ATR,ATRX,BRCA2,ERCC5
Monarch	HP:0004298	Abnormality of the abdominal wall	6	415	1.09	0.00036	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FANCM,ATRX,AR,BRCA2,PIK3R1,PTPN11
Monarch	HP:0030448	Soft tissue sarcoma	4	104	1.52	0.00036	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000364699,9606.ENSP00000489597	CDKN1B,MSH2,SDHD,PTPN11
Monarch	HP:0000752	Hyperactivity	6	423	1.08	0.00039	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441	MSH2,NTRK2,ARID1A,ATR,SMARCA4,ATRX
Monarch	HP:0011968	Feeding difficulties	8	947	0.86	0.00039	9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000489597,9606.ENSP00000498881	FUS,NTRK2,ARID1A,SMARCA4,ATRX,SDHD,PTPN11,ERCC5
Monarch	HP:0000202	Oral cleft	7	665	0.95	0.00040	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	RB1,FANCM,RSPO2,ATR,BRCA2,PTPN11,ERCC5
Monarch	HP:0000365	Hearing impairment	9	1288	0.78	0.00040	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0006727	T-cell acute lymphoblastic leukemias	2	2	2.93	0.00040	9606.ENSP00000233146,9606.ENSP00000369497	MSH2,BRCA2
Monarch	HP:0002242	Abnormal intestine morphology	7	673	0.95	0.00043	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000500891	MSH2,FANCM,ATRX,SDHD,BRCA2,PIK3R1,MUTYH
Monarch	HP:0000144	Decreased fertility	5	245	1.24	0.00044	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,WRN,AR,BRCA2,PTPN11
Monarch	HP:0011314	Abnormal long bone morphology	7	675	0.95	0.00044	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	RB1,FANCM,ATR,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0001643	Patent ductus arteriosus	5	246	1.24	0.00045	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ARID1A,SMARCA4,BRCA2,PTPN11
Monarch	HP:0000158	Macroglossia	4	113	1.48	0.00047	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699	ARID1A,SMARCA4,ATRX,SDHD
Monarch	HP:0030255	Large intestinal polyposis	3	33	1.89	0.00047	9606.ENSP00000233146,9606.ENSP00000364699,9606.ENSP00000500891	MSH2,SDHD,MUTYH
Monarch	HP:0001009	Telangiectasia	4	114	1.48	0.00048	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000364699,9606.ENSP00000498881	WRN,ATR,SDHD,ERCC5
Monarch	HP:0000545	Myopia	6	446	1.06	0.00049	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597	ARID1A,SMARCA4,ATRX,SDHD,PIK3R1,PTPN11
Monarch	HP:0000324	Facial asymmetry	4	116	1.47	0.00051	9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000343741,9606.ENSP00000369497	FANCM,NTRK2,ATR,BRCA2
Monarch	HP:0000050	Hypoplastic male external genitalia	6	452	1.06	0.00052	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,ATRX,AR,PTPN11,ERCC5
Monarch	HP:0000069	Abnormality of the ureter	5	257	1.22	0.00053	9606.ENSP00000267430,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497	FANCM,MCPH1,ATRX,SDHD,BRCA2
Monarch	HP:0010993	Abnormal cerebral subcortex morphology	8	999	0.84	0.00053	9606.ENSP00000233146,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441	MSH2,RSPO2,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX
Monarch	HP:0030809	Abnormal tongue morphology	5	258	1.22	0.00053	9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699	RSPO2,ARID1A,SMARCA4,ATRX,SDHD
Monarch	HP:0031105	Abnormal uterus morphology	4	119	1.46	0.00055	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000364699,9606.ENSP00000369497	MSH2,FANCM,SDHD,BRCA2
Monarch	HP:0000921	Missing ribs	3	36	1.85	0.00058	9606.ENSP00000276659,9606.ENSP00000343741,9606.ENSP00000489597	RSPO2,ATR,PTPN11
Monarch	HP:0008678	Renal hypoplasia/aplasia	5	264	1.21	0.00058	9606.ENSP00000267430,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,MCPH1,ATRX,BRCA2,PTPN11
Monarch	HP:0031704	Abnormal ear physiology	9	1362	0.75	0.00058	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0100022	Abnormality of movement	10	1758	0.69	0.00058	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	MSH2,FUS,FANCM,NTRK2,MCPH1,ATRX,AR,SDHD,BRCA2,ERCC5
Monarch	HP:0003808	Abnormal muscle tone	10	1773	0.68	0.00062	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,FUS,NTRK2,ARID1A,SMARCA4,ATRX,AR,SDHD,PTPN11,ERCC5
Monarch	HP:0100743	Neoplasm of the rectum	3	37	1.84	0.00062	9606.ENSP00000233146,9606.ENSP00000364699,9606.ENSP00000500891	MSH2,SDHD,MUTYH
Monarch	HP:0100887	Abnormality of globe size	5	268	1.2	0.00062	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000498881	FANCM,RSPO2,ATR,BRCA2,ERCC5
Monarch	HP:0001480	Freckling	3	38	1.83	0.00065	9606.ENSP00000233146,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,PTPN11,ERCC5
Monarch	HP:0011017	Abnormal cellular physiology	6	473	1.04	0.00065	9606.ENSP00000267430,9606.ENSP00000342924,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000498881	FANCM,MCPH1,SDHD,BRCA2,PIK3R1,ERCC5
Monarch	HP:0001636	Tetralogy of Fallot	4	128	1.43	0.00069	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497	FANCM,ARID1A,SMARCA4,BRCA2
Monarch	HP:0005927	Aplasia/hypoplasia involving bones of the hand	6	480	1.03	0.00069	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,WRN,ARID1A,SMARCA4,BRCA2,PIK3R1
Monarch	HP:0000179	Thick lower lip vermilion	4	133	1.41	0.00079	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000489597	ARID1A,SMARCA4,ATRX,PTPN11
Monarch	HP:0012041	Decreased fertility in males	4	133	1.41	0.00079	9606.ENSP00000267430,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,AR,BRCA2,PTPN11
Monarch	HP:0033019	Male reproductive system neoplasm	3	41	1.8	0.00079	9606.ENSP00000228872,9606.ENSP00000363822,9606.ENSP00000369497	CDKN1B,AR,BRCA2
Monarch	HP:0002683	Abnormal calvaria morphology	7	762	0.9	0.00083	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,ATR,ATRX,BRCA2,PIK3R1,PTPN11,ERCC5
Monarch	HP:0002118	Abnormal cerebral ventricle morphology	7	765	0.89	0.00085	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000498881	FANCM,RSPO2,ARID1A,MCPH1,SMARCA4,BRCA2,ERCC5
Monarch	HP:0010463	Aplasia of the ovary	2	4	2.63	0.00085	9606.ENSP00000363822,9606.ENSP00000489597	AR,PTPN11
Monarch	HP:0004209	Clinodactyly of the 5th finger	5	292	1.17	0.00088	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ATR,ATRX,BRCA2,PTPN11
Monarch	HP:0009179	Deviation of the 5th finger	5	293	1.16	0.00089	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ATR,ATRX,BRCA2,PTPN11
Monarch	HP:0001273	Abnormal corpus callosum morphology	7	784	0.88	0.00098	9606.ENSP00000233146,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441	MSH2,RSPO2,NTRK2,ARID1A,MCPH1,SMARCA4,ATRX
Monarch	HP:0004328	Abnormal anterior eye segment morphology	8	1106	0.79	0.00099	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000498881	RB1,FANCM,RSPO2,WRN,SDHD,BRCA2,PIK3R1,ERCC5
Monarch	HP:0012740	Papilloma	3	45	1.76	0.00099	9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000498881	SDHD,PIK3R1,ERCC5
Monarch	HP:0100012	Neoplasm of the eye	3	45	1.76	0.00099	9606.ENSP00000267163,9606.ENSP00000364699,9606.ENSP00000498881	RB1,SDHD,ERCC5
Monarch	HP:0100037	Abnormality of the scalp hair	5	302	1.15	0.0010	9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000489597	WRN,ARID1A,ATR,SMARCA4,PTPN11
Monarch	HP:0000864	Abnormality of the hypothalamus-pituitary axis	5	314	1.13	0.0012	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000363822,9606.ENSP00000369497	CDKN1B,MSH2,FANCM,AR,BRCA2
Monarch	HP:0001098	Abnormal fundus morphology	8	1143	0.78	0.0012	9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000498881,9606.ENSP00000500891	RB1,RSPO2,NTRK2,WRN,ATRX,SDHD,ERCC5,MUTYH
Monarch	HP:0001156	Brachydactyly	5	313	1.14	0.0012	9606.ENSP00000320485,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597	ARID1A,ATRX,SDHD,PIK3R1,PTPN11
Monarch	HP:0001252	Hypotonia	9	1505	0.71	0.0012	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,NTRK2,ARID1A,SMARCA4,ATRX,AR,SDHD,PTPN11,ERCC5
Monarch	HP:0002814	Abnormality of the lower limb	9	1506	0.71	0.0012	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	RB1,FANCM,WRN,ATR,ATRX,AR,SDHD,BRCA2,ERCC5
Monarch	HP:0100606	Neoplasm of the respiratory system	3	49	1.72	0.0012	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139	MSH2,RB1,WRN
Monarch	HP:0001600	Abnormality of the larynx	4	154	1.35	0.0013	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000276659,9606.ENSP00000298139	MSH2,FUS,RSPO2,WRN
Monarch	HP:0002894	Neoplasm of the pancreas	3	52	1.69	0.0014	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000369497	CDKN1B,MSH2,BRCA2
Monarch	HP:0100615	Ovarian neoplasm	3	52	1.69	0.0014	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000369497	MSH2,WRN,BRCA2
Monarch	HP:0000340	Sloping forehead	4	161	1.33	0.0015	9606.ENSP00000267430,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000369497	FANCM,MCPH1,ATR,BRCA2
Monarch	HP:0004326	Cachexia	3	56	1.66	0.0017	9606.ENSP00000254108,9606.ENSP00000343741,9606.ENSP00000498881	FUS,ATR,ERCC5
Monarch	HP:0009466	Radial deviation of finger	3	55	1.67	0.0017	9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000489597	ATRX,PIK3R1,PTPN11
Monarch	HP:0030063	Neuroepithelial neoplasm	3	55	1.67	0.0017	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000489597	MSH2,RB1,PTPN11
Monarch	HP:0100007	Neoplasm of the peripheral nervous system	3	56	1.66	0.0017	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000364699	CDKN1B,MSH2,SDHD
Monarch	HP:0000159	Abnormal lip morphology	7	878	0.83	0.0018	9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000489597,9606.ENSP00000498881	RSPO2,ARID1A,MCPH1,SMARCA4,ATRX,PTPN11,ERCC5
Monarch	HP:0001250	Seizure	9	1607	0.68	0.0018	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000498881	MSH2,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,ATRX,SDHD,ERCC5
Monarch	HP:0100851	Abnormal emotion/affect behavior	6	586	0.94	0.0018	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699	MSH2,FUS,ARID1A,SMARCA4,ATRX,SDHD
Monarch	HP:0002672	Gastrointestinal carcinoma	3	58	1.65	0.0019	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000500891	MSH2,WRN,MUTYH
Monarch	HP:0002818	Abnormal morphology of the radius	4	174	1.29	0.0019	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ATR,BRCA2,PTPN11
Monarch	HP:0000995	Melanocytic nevus	3	60	1.63	0.0020	9606.ENSP00000364699,9606.ENSP00000489597,9606.ENSP00000498881	SDHD,PTPN11,ERCC5
Monarch	HP:0001376	Limitation of joint mobility	5	356	1.08	0.0020	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000489597,9606.ENSP00000498881	WRN,ATR,ATRX,PTPN11,ERCC5
Monarch	HP:0000175	Cleft palate	6	617	0.92	0.0024	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	RB1,FANCM,ATR,BRCA2,PTPN11,ERCC5
Monarch	HP:0004299	Hernia of the abdominal wall	5	371	1.06	0.0024	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,ATRX,AR,BRCA2,PIK3R1
Monarch	HP:0011603	Congenital malformation of the great arteries	5	371	1.06	0.0024	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ARID1A,SMARCA4,BRCA2,PTPN11
Monarch	HP:0012337	Abnormal homeostasis	8	1275	0.73	0.0024	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,RB1,WRN,AR,SDHD,PIK3R1,PTPN11,ERCC5
Monarch	HP:0001629	Ventricular septal defect	5	378	1.05	0.0025	9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000489597	RSPO2,ARID1A,SMARCA4,ATRX,PTPN11
Monarch	HP:0010866	Abdominal wall defect	5	375	1.06	0.0025	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,ATRX,AR,BRCA2,PIK3R1
Monarch	HP:0000639	Nystagmus	7	936	0.81	0.0026	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FUS,FANCM,NTRK2,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0009124	Abnormal adipose tissue morphology	4	190	1.26	0.0026	9606.ENSP00000228872,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000428056	CDKN1B,WRN,SDHD,PIK3R1
Monarch	HP:0011119	Abnormal nasal dorsum morphology	4	191	1.25	0.0026	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000489597	WRN,ATR,ATRX,PTPN11
Monarch	HP:0012547	Abnormal involuntary eye movements	7	943	0.8	0.0027	9606.ENSP00000254108,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FUS,FANCM,NTRK2,SDHD,BRCA2,PTPN11,ERCC5
Monarch	HP:0010864	Intellectual disability, severe	5	390	1.04	0.0028	9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441	NTRK2,ARID1A,MCPH1,SMARCA4,ATRX
Monarch	HP:0009821	Forearm undergrowth	3	71	1.56	0.0031	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000369497	FANCM,ATR,BRCA2
Monarch	HP:0012888	Abnormal uterine cervix morphology	2	10	2.23	0.0031	9606.ENSP00000228872,9606.ENSP00000363822	CDKN1B,AR
Monarch	HP:0030731	Carcinoma	2	10	2.23	0.0031	9606.ENSP00000228872,9606.ENSP00000233146	CDKN1B,MSH2
Monarch	HP:0011951	Aspiration pneumonia	3	72	1.55	0.0032	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699	ARID1A,SMARCA4,SDHD
Monarch	HP:0100738	Abnormal eating behavior	3	72	1.55	0.0032	9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896	NTRK2,ARID1A,SMARCA4
Monarch	HP:0001371	Flexion contracture	6	664	0.89	0.0033	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000498881	MSH2,FUS,ATR,ATRX,SDHD,ERCC5
Monarch	HP:0012649	Increased inflammatory response	7	981	0.79	0.0033	9606.ENSP00000228872,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000498881	CDKN1B,ARID1A,SMARCA4,AR,SDHD,PIK3R1,ERCC5
Monarch	HP:0034392	Joint contracture	6	664	0.89	0.0033	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000498881	MSH2,FUS,ATR,ATRX,SDHD,ERCC5
Monarch	HP:0011563	Abnormal ventriculoarterial connection	4	208	1.22	0.0034	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497	FANCM,ARID1A,SMARCA4,BRCA2
Monarch	HP:0001892	Abnormal bleeding	5	411	1.02	0.0035	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000489597	MSH2,RB1,ATRX,SDHD,PTPN11
Monarch	HP:0008398	Hypoplastic fifth fingernail	2	11	2.19	0.0035	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0100835	Benign neoplasm of the central nervous system	3	78	1.52	0.0038	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000364699	MSH2,WRN,SDHD
Monarch	HP:0000054	Micropenis	4	217	1.2	0.0039	9606.ENSP00000276659,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000489597	RSPO2,ATRX,AR,PTPN11
Monarch	HP:0006501	Aplasia/Hypoplasia of the radius	3	81	1.5	0.0042	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000369497	FANCM,ATR,BRCA2
Monarch	HP:0002538	Abnormal cerebral cortex morphology	6	704	0.86	0.0043	9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000498881	ARID1A,MCPH1,ATR,SMARCA4,ATRX,ERCC5
Monarch	HP:0010514	Hyperpituitarism	3	82	1.5	0.0044	9606.ENSP00000228872,9606.ENSP00000267430,9606.ENSP00000363822	CDKN1B,FANCM,AR
Monarch	HP:0000708	Behavioral abnormality	9	1839	0.62	0.0045	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000498881	MSH2,FUS,NTRK2,ARID1A,ATR,SMARCA4,ATRX,SDHD,ERCC5
Monarch	HP:0011231	Prominent eyelashes	2	13	2.12	0.0045	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0011937	Hypoplastic fifth toenail	2	13	2.12	0.0045	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0033725	Thin corpus callosum	6	709	0.86	0.0045	9606.ENSP00000233146,9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441	MSH2,RSPO2,ARID1A,MCPH1,SMARCA4,ATRX
Monarch	HP:0002719	Recurrent infections	6	721	0.85	0.0048	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,ARID1A,SMARCA4,ATRX,BRCA2,PIK3R1
Monarch	HP:0000286	Epicanthus	5	447	0.98	0.0049	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FANCM,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0008572	External ear malformation	3	86	1.48	0.0049	9606.ENSP00000267430,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,BRCA2,PIK3R1
Monarch	HP:0011747	Abnormality of the anterior pituitary	4	233	1.17	0.0050	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000363822	CDKN1B,MSH2,FANCM,AR
Monarch	HP:0012523	Oral aversion	2	14	2.09	0.0051	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0000568	Microphthalmia	4	239	1.16	0.0055	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000369497,9606.ENSP00000498881	FANCM,RSPO2,BRCA2,ERCC5
Monarch	HP:0000729	Autistic behavior	5	460	0.97	0.0055	9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699	NTRK2,ARID1A,SMARCA4,ATRX,SDHD
Monarch	HP:0002665	Lymphoma	3	90	1.46	0.0055	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000428056	MSH2,RB1,PIK3R1
Monarch	HP:0000765	Abnormal thorax morphology	6	743	0.84	0.0056	9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000489597	RSPO2,WRN,ATR,AR,SDHD,PTPN11
Monarch	HP:0001639	Hypertrophic cardiomyopathy	4	241	1.15	0.0056	9606.ENSP00000267430,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,SDHD,BRCA2,PTPN11
Monarch	EFO:0010574	Epithelial cell adhesion molecule measurement	2	15	2.06	0.0057	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
Monarch	HP:0032101	Unusual infection	6	748	0.84	0.0057	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,ARID1A,SMARCA4,ATRX,BRCA2,PIK3R1
Monarch	HP:0002269	Abnormality of neuronal migration	5	466	0.96	0.0058	9606.ENSP00000233146,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896	MSH2,ARID1A,MCPH1,ATR,SMARCA4
Monarch	HP:0000027	Azoospermia	3	93	1.44	0.0059	9606.ENSP00000267430,9606.ENSP00000363822,9606.ENSP00000369497	FANCM,AR,BRCA2
Monarch	HP:0011361	Congenital abnormal hair pattern	4	247	1.14	0.0060	9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000489597	WRN,ARID1A,SMARCA4,PTPN11
Monarch	HP:0002414	Spina bifida	3	94	1.44	0.0061	9606.ENSP00000267430,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,BRCA2,PTPN11
Monarch	HP:0002896	Neoplasm of the liver	3	96	1.43	0.0064	9606.ENSP00000233146,9606.ENSP00000320485,9606.ENSP00000343896	MSH2,ARID1A,SMARCA4
Monarch	HP:0002823	Abnormality of femur morphology	4	253	1.13	0.0065	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497	RB1,FANCM,ATRX,BRCA2
Monarch	HP:0009127	Abnormality of the musculature of the limbs	5	481	0.95	0.0066	9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000489597	NTRK2,ATRX,AR,SDHD,PTPN11
Monarch	HP:0000010	Recurrent urinary tract infections	3	99	1.41	0.0069	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497	FANCM,ATRX,BRCA2
Monarch	HP:0002488	Acute leukemia	3	99	1.41	0.0069	9606.ENSP00000233146,9606.ENSP00000362441,9606.ENSP00000369497	MSH2,ATRX,BRCA2
Monarch	HP:0100833	Neoplasm of the small intestine	2	17	2.0	0.0069	9606.ENSP00000233146,9606.ENSP00000298139	MSH2,WRN
Monarch	HP:0000582	Upslanted palpebral fissure	4	259	1.12	0.0070	9606.ENSP00000267430,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497	FANCM,MCPH1,ATRX,BRCA2
Monarch	HP:0001197	Abnormality of prenatal development or birth	6	786	0.82	0.0072	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000498881	FANCM,RSPO2,NTRK2,BRCA2,PTPN11,ERCC5
Monarch	HP:0001337	Tremor	5	492	0.94	0.0072	9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000498881	FUS,NTRK2,AR,SDHD,ERCC5
Monarch	HP:0001317	Abnormal cerebellum morphology	6	788	0.81	0.0073	9606.ENSP00000254108,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000498881	FUS,ARID1A,ATR,SMARCA4,SDHD,ERCC5
Monarch	HP:0006712	Aplasia/Hypoplasia of the ribs	3	102	1.4	0.0074	9606.ENSP00000276659,9606.ENSP00000343741,9606.ENSP00000489597	RSPO2,ATR,PTPN11
Monarch	HP:0005227	Adenomatous colonic polyposis	2	18	1.98	0.0075	9606.ENSP00000233146,9606.ENSP00000500891	MSH2,MUTYH
Monarch	HP:0008872	Feeding difficulties in infancy	5	499	0.93	0.0075	9606.ENSP00000254108,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000489597,9606.ENSP00000498881	FUS,ATRX,SDHD,PTPN11,ERCC5
Monarch	HP:0011027	Abnormal fallopian tube morphology	2	18	1.98	0.0075	9606.ENSP00000363822,9606.ENSP00000369497	AR,BRCA2
Monarch	HP:0011969	Elevated circulating luteinizing hormone level	2	18	1.98	0.0075	9606.ENSP00000267430,9606.ENSP00000363822	FANCM,AR
Monarch	HP:0000689	Dental malocclusion	3	104	1.39	0.0077	9606.ENSP00000343741,9606.ENSP00000428056,9606.ENSP00000489597	ATR,PIK3R1,PTPN11
Monarch	HP:0000219	Thin upper lip vermilion	4	269	1.11	0.0078	9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441	ARID1A,MCPH1,SMARCA4,ATRX
Monarch	HP:0006824	Cranial nerve paralysis	4	271	1.1	0.0080	9606.ENSP00000267430,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,SDHD,BRCA2,PTPN11
Monarch	HP:0002895	Papillary thyroid carcinoma	2	19	1.95	0.0081	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0005607	Abnormal tracheobronchial morphology	4	278	1.09	0.0087	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,RSPO2,BRCA2,PIK3R1
Monarch	HP:0002884	Hepatoblastoma	2	20	1.93	0.0088	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0008232	Elevated circulating follicle stimulating hormone level	2	20	1.93	0.0088	9606.ENSP00000267430,9606.ENSP00000363822	FANCM,AR
Monarch	HP:0009720	Adenoma sebaceum	2	20	1.93	0.0088	9606.ENSP00000233146,9606.ENSP00000364699	MSH2,SDHD
Monarch	HP:0040202	Abnormal consumption behavior	3	111	1.36	0.0090	9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896	NTRK2,ARID1A,SMARCA4
Monarch	HP:0002509	Limb hypertonia	3	112	1.36	0.0092	9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000364699	NTRK2,ATRX,SDHD
Monarch	HP:0000429	Abnormal morphology of the nasal alae	5	531	0.91	0.0094	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000498881	ARID1A,SMARCA4,ATRX,PIK3R1,ERCC5
Monarch	HP:0000692	Tooth malposition	4	286	1.08	0.0094	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000489597	ATR,ATRX,PIK3R1,PTPN11
Monarch	HP:0002023	Anal atresia	3	113	1.36	0.0094	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000369497	FANCM,RSPO2,BRCA2
Monarch	HP:0002251	Aganglionic megacolon	3	113	1.36	0.0094	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497	FANCM,ATRX,BRCA2
Monarch	HP:0004362	Abnormality of enteric ganglion morphology	3	113	1.36	0.0094	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497	FANCM,ATRX,BRCA2
Monarch	HP:0012719	Functional abnormality of the gastrointestinal tract	6	840	0.79	0.0095	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699	MSH2,FUS,NTRK2,ATRX,AR,SDHD
Monarch	HP:0040071	Abnormal morphology of ulna	3	115	1.35	0.0097	9606.ENSP00000267430,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,BRCA2,PTPN11
Monarch	HP:0200063	Colorectal polyposis	2	22	1.89	0.0101	9606.ENSP00000364699,9606.ENSP00000500891	SDHD,MUTYH
Monarch	HP:0000648	Optic atrophy	5	548	0.89	0.0107	9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000498881	RSPO2,NTRK2,ATRX,SDHD,ERCC5
Monarch	HP:0005522	Pyridoxine-responsive sideroblastic anemia	2	23	1.87	0.0109	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0000502	Abnormal conjunctiva morphology	3	122	1.32	0.0114	9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000498881	SDHD,PIK3R1,ERCC5
Monarch	HP:0100491	Abnormality of lower limb joint	5	558	0.89	0.0116	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497	FANCM,ATR,ATRX,SDHD,BRCA2
Monarch	HP:0001873	Thrombocytopenia	4	305	1.05	0.0117	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ATRX,BRCA2,PTPN11
Monarch	HP:0005262	Abnormality of the synovia	4	305	1.05	0.0117	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ATR,BRCA2,PTPN11
Monarch	HP:0012114	Endometrial carcinoma	2	24	1.85	0.0117	9606.ENSP00000233146,9606.ENSP00000364699	MSH2,SDHD
Monarch	HP:0012810	Wide nasal base	2	24	1.85	0.0117	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0001760	Abnormal foot morphology	7	1253	0.68	0.0118	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881	FANCM,WRN,ATR,ATRX,SDHD,BRCA2,ERCC5
Monarch	HP:0002376	Developmental regression	4	307	1.05	0.0118	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000364699,9606.ENSP00000498881	MSH2,NTRK2,SDHD,ERCC5
Monarch	HP:0008734	Decreased testicular size	3	124	1.32	0.0118	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000498881	FANCM,ATRX,ERCC5
Monarch	HP:0000076	Vesicoureteral reflux	3	125	1.31	0.0119	9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000364699	MCPH1,ATRX,SDHD
Monarch	HP:0001763	Pes planus	4	308	1.05	0.0119	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	FANCM,ATR,ATRX,BRCA2
Monarch	HP:0031065	Abnormal ovarian morphology	3	125	1.31	0.0119	9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000489597	AR,SDHD,PTPN11
Monarch	HP:0031466	Impairment in personality functioning	5	566	0.88	0.0120	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000364699	MSH2,FUS,NTRK2,ATRX,SDHD
Monarch	HP:0010293	Aplasia/Hypoplasia of the uvula	2	25	1.84	0.0124	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0010469	Absent testis	2	25	1.84	0.0124	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0000422	Abnormal nasal bridge morphology	6	897	0.76	0.0128	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	ARID1A,SMARCA4,ATRX,PIK3R1,PTPN11,ERCC5
Monarch	HP:0001257	Spasticity	6	897	0.76	0.0128	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000498881	MSH2,FUS,NTRK2,ATRX,SDHD,ERCC5
Monarch	HP:0006265	Aplasia/Hypoplasia of fingers	4	315	1.04	0.0128	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497	FANCM,ARID1A,SMARCA4,BRCA2
Monarch	HP:0006895	Lower limb hypertonia	2	26	1.82	0.0131	9606.ENSP00000362441,9606.ENSP00000364699	ATRX,SDHD
Monarch	HP:0010788	Testicular neoplasm	2	26	1.82	0.0131	9606.ENSP00000228872,9606.ENSP00000363822	CDKN1B,AR
Monarch	HP:0100634	Neuroendocrine neoplasm	2	26	1.82	0.0131	9606.ENSP00000228872,9606.ENSP00000364699	CDKN1B,SDHD
Monarch	HP:0003508	Proportionate short stature	3	131	1.29	0.0132	9606.ENSP00000343741,9606.ENSP00000364699,9606.ENSP00000428056	ATR,SDHD,PIK3R1
Monarch	HP:0000717	Autism	3	132	1.29	0.0135	9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000364699	NTRK2,ATRX,SDHD
Monarch	HP:0002778	Abnormal tracheal morphology	3	132	1.29	0.0135	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000369497	FANCM,RSPO2,BRCA2
Monarch	HP:0011873	Abnormal platelet count	4	323	1.03	0.0137	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,ATRX,BRCA2,PTPN11
Monarch	HP:0002893	Pituitary adenoma	2	27	1.8	0.0138	9606.ENSP00000228872,9606.ENSP00000233146	CDKN1B,MSH2
Monarch	HP:0034353	Appendicular spasticity	4	324	1.02	0.0138	9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000364699	FUS,NTRK2,ATRX,SDHD
Monarch	HP:0001547	Abnormal rib cage morphology	4	325	1.02	0.0139	9606.ENSP00000276659,9606.ENSP00000343741,9606.ENSP00000363822,9606.ENSP00000489597	RSPO2,ATR,AR,PTPN11
Monarch	EFO:0005278	Cardiovascular disease biomarker measurement	9	2228	0.54	0.0149	9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	WRN,ARID1A,MCPH1,SMARCA4,TFEB,ROS1,AR,BRCA2,PTPN11
Monarch	HP:0011277	Abnormality of the urinary system physiology	6	933	0.74	0.0152	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000498881,9606.ENSP00000500891	FANCM,ATRX,SDHD,BRCA2,ERCC5,MUTYH
Monarch	HP:0002574	Episodic abdominal pain	2	29	1.77	0.0156	9606.ENSP00000228872,9606.ENSP00000364699	CDKN1B,SDHD
Monarch	HP:0011337	Abnormality of mouth size	4	337	1.01	0.0156	9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441	RSPO2,ARID1A,SMARCA4,ATRX
Monarch	HP:0012539	Non-Hodgkin lymphoma	2	29	1.77	0.0156	9606.ENSP00000233146,9606.ENSP00000428056	MSH2,PIK3R1
Monarch	HP:0100867	Duodenal stenosis	2	29	1.77	0.0156	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0003121	Limb joint contracture	4	339	1.0	0.0159	9606.ENSP00000254108,9606.ENSP00000343741,9606.ENSP00000364699,9606.ENSP00000498881	FUS,ATR,SDHD,ERCC5
Monarch	HP:0002119	Ventriculomegaly	5	612	0.84	0.0161	9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000369497	FANCM,ARID1A,MCPH1,SMARCA4,BRCA2
Monarch	HP:0002669	Osteosarcoma	2	30	1.76	0.0163	9606.ENSP00000267163,9606.ENSP00000298139	RB1,WRN
Monarch	HP:0005692	Joint hyperflexibility	3	144	1.25	0.0163	9606.ENSP00000343741,9606.ENSP00000428056,9606.ENSP00000489597	ATR,PIK3R1,PTPN11
Monarch	HP:0032148	Episodic pain	2	30	1.76	0.0163	9606.ENSP00000228872,9606.ENSP00000364699	CDKN1B,SDHD
Monarch	HP:0040276	Adenocarcinoma of the colon	2	30	1.76	0.0163	9606.ENSP00000233146,9606.ENSP00000500891	MSH2,MUTYH
Monarch	HP:0100587	Abnormal preputium morphology	2	30	1.76	0.0163	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0100631	Neoplasm of the adrenal gland	2	30	1.76	0.0163	9606.ENSP00000228872,9606.ENSP00000364699	CDKN1B,SDHD
Monarch	HP:0100760	Clubbing of toes	2	30	1.76	0.0163	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0000238	Hydrocephalus	4	345	1.0	0.0166	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000369497,9606.ENSP00000498881	FANCM,RSPO2,BRCA2,ERCC5
Monarch	HP:0025270	Abnormal esophagus physiology	5	619	0.84	0.0166	9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699	FUS,NTRK2,ATRX,AR,SDHD
Monarch	EFO:0004611	Low density lipoprotein cholesterol measurement	5	624	0.84	0.0171	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	ARID1A,SMARCA4,AR,BRCA2,PTPN11
Monarch	HP:0000009	Functional abnormality of the bladder	4	349	0.99	0.0171	9606.ENSP00000254108,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000364699	FUS,MCPH1,ATRX,SDHD
Monarch	HP:0100579	Mucosal telangiectasiae	2	32	1.73	0.0178	9606.ENSP00000364699,9606.ENSP00000498881	SDHD,ERCC5
Monarch	HP:0001387	Joint stiffness	3	151	1.23	0.0183	9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000498881	WRN,ATRX,ERCC5
Monarch	HP:0003117	Abnormal circulating hormone concentration	4	357	0.98	0.0184	9606.ENSP00000228872,9606.ENSP00000267430,9606.ENSP00000363822,9606.ENSP00000364699	CDKN1B,FANCM,AR,SDHD
Monarch	HP:0002858	Meningioma	2	33	1.72	0.0187	9606.ENSP00000298139,9606.ENSP00000364699	WRN,SDHD
Monarch	EFO:0004615	Apolipoprotein B measurement	4	360	0.98	0.0189	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000489597	ARID1A,SMARCA4,BRCA2,PTPN11
Monarch	HP:0009928	Thick nasal alae	2	34	1.7	0.0197	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0000316	Hypertelorism	5	650	0.82	0.0199	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FANCM,ATRX,BRCA2,PIK3R1,PTPN11
Monarch	HP:0000369	Low-set ears	5	649	0.82	0.0199	9606.ENSP00000276659,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000489597,9606.ENSP00000498881	RSPO2,ATR,ATRX,PTPN11,ERCC5
Monarch	HP:0011893	Abnormal leukocyte count	4	367	0.97	0.0201	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056	FANCM,ATRX,BRCA2,PIK3R1
Monarch	HP:0000268	Dolichocephaly	3	158	1.21	0.0205	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497	FANCM,ATRX,BRCA2
Monarch	HP:0002017	Nausea and vomiting	4	369	0.97	0.0205	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000362441,9606.ENSP00000364699	MSH2,FUS,ATRX,SDHD
Monarch	HP:0003003	Colon cancer	2	35	1.69	0.0205	9606.ENSP00000233146,9606.ENSP00000500891	MSH2,MUTYH
Monarch	HP:0007392	Excessive wrinkled skin	2	35	1.69	0.0205	9606.ENSP00000428056,9606.ENSP00000489597	PIK3R1,PTPN11
Monarch	HP:0007874	Almond-shaped palpebral fissure	2	35	1.69	0.0205	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0012031	Lipomatous tumor	2	35	1.69	0.0205	9606.ENSP00000228872,9606.ENSP00000364699	CDKN1B,SDHD
Monarch	HP:0010972	Anemia of inadequate production	3	160	1.21	0.0209	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497	FANCM,ATRX,BRCA2
Monarch	HP:0011339	Abnormality of upper lip vermillion	4	373	0.96	0.0210	9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441	ARID1A,MCPH1,SMARCA4,ATRX
Monarch	HP:0100530	Abnormal calcium-phosphate regulating hormone level	2	36	1.68	0.0214	9606.ENSP00000228872,9606.ENSP00000364699	CDKN1B,SDHD
Monarch	HP:0000154	Wide mouth	3	163	1.2	0.0219	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441	ARID1A,SMARCA4,ATRX
Monarch	EFO:0004324	Body weights and measures	12	4122	0.4	0.0221	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,RB1,RSPO2,NTRK2,ARID1A,MCPH1,SMARCA4,TFEB,SDHD,PIK3R1,PTPN11
Monarch	HP:0003006	Neuroblastoma	2	37	1.67	0.0223	9606.ENSP00000233146,9606.ENSP00000489597	MSH2,PTPN11
Monarch	HP:0000481	Abnormal cornea morphology	5	673	0.8	0.0224	9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000498881	FANCM,RSPO2,BRCA2,PIK3R1,ERCC5
Monarch	HP:0001608	Abnormality of the voice	4	384	0.95	0.0228	9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000489597	WRN,AR,SDHD,PTPN11
Monarch	HP:0002536	Abnormal cortical gyration	4	384	0.95	0.0228	9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896	ARID1A,MCPH1,ATR,SMARCA4
Monarch	HP:0000104	Renal agenesis	3	167	1.19	0.0230	9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000489597	MCPH1,ATRX,PTPN11
Monarch	HP:0000022	Abnormal male internal genitalia morphology	2	38	1.65	0.0231	9606.ENSP00000363822,9606.ENSP00000369497	AR,BRCA2
Monarch	HP:0000357	Abnormal location of ears	5	679	0.8	0.0231	9606.ENSP00000276659,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000489597,9606.ENSP00000498881	RSPO2,ATR,ATRX,PTPN11,ERCC5
Monarch	HP:0001658	Myocardial infarction	2	38	1.65	0.0231	9606.ENSP00000298139,9606.ENSP00000489597	WRN,PTPN11
Monarch	HP:0008736	Hypoplasia of penis	4	387	0.95	0.0231	9606.ENSP00000276659,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000489597	RSPO2,ATRX,AR,PTPN11
Monarch	HP:0008065	Aplasia/Hypoplasia of the skin	3	170	1.18	0.0238	9606.ENSP00000298139,9606.ENSP00000428056,9606.ENSP00000498881	WRN,PIK3R1,ERCC5
Monarch	HP:0001264	Spastic diplegia	2	39	1.64	0.0239	9606.ENSP00000254108,9606.ENSP00000277120	FUS,NTRK2
Monarch	HP:0002027	Abdominal pain	3	172	1.17	0.0245	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000364699	CDKN1B,MSH2,SDHD
Monarch	HP:0010647	Abnormal elasticity of skin	3	172	1.17	0.0245	9606.ENSP00000298139,9606.ENSP00000428056,9606.ENSP00000489597	WRN,PIK3R1,PTPN11
Monarch	HP:0000280	Coarse facial features	3	174	1.17	0.0251	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441	ARID1A,SMARCA4,ATRX
Monarch	HP:0000037	Male pseudohermaphroditism	2	41	1.62	0.0259	9606.ENSP00000362441,9606.ENSP00000363822	ATRX,AR
Monarch	HP:0000684	Delayed eruption of teeth	3	181	1.15	0.0278	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000428056	ARID1A,SMARCA4,PIK3R1
Monarch	HP:0100526	Neoplasm of the lung	2	43	1.6	0.0281	9606.ENSP00000267163,9606.ENSP00000298139	RB1,WRN
Monarch	HP:0000177	Abnormal upper lip morphology	5	720	0.77	0.0288	9606.ENSP00000276659,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441	RSPO2,ARID1A,MCPH1,SMARCA4,ATRX
Monarch	HP:0007360	Aplasia/Hypoplasia of the cerebellum	4	419	0.91	0.0300	9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000498881	ARID1A,ATR,SMARCA4,ERCC5
Monarch	HP:0002493	Upper motor neuron dysfunction	6	1100	0.67	0.0304	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000498881	MSH2,FUS,NTRK2,ATRX,SDHD,ERCC5
Monarch	HP:0000289	Broad philtrum	2	46	1.57	0.0316	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0002671	Basal cell carcinoma	2	46	1.57	0.0316	9606.ENSP00000233146,9606.ENSP00000498881	MSH2,ERCC5
Monarch	HP:0002997	Obsolete Abnormality of the ulna	2	46	1.57	0.0316	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0002721	Immunodeficiency	3	192	1.13	0.0321	9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056	ATRX,SDHD,PIK3R1
Monarch	HP:0001596	Alopecia	3	193	1.12	0.0325	9606.ENSP00000343741,9606.ENSP00000428056,9606.ENSP00000498881	ATR,PIK3R1,ERCC5
Monarch	HP:0004930	Abnormality of the pulmonary vasculature	3	194	1.12	0.0328	9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000489597	RSPO2,WRN,PTPN11
Monarch	EFO:0004344	Birth weight	3	196	1.12	0.0337	9606.ENSP00000267163,9606.ENSP00000342924,9606.ENSP00000428056	RB1,MCPH1,PIK3R1
Monarch	HP:0008947	Infantile muscular hypotonia	3	197	1.12	0.0341	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441	ARID1A,SMARCA4,ATRX
Monarch	HP:0010766	Ectopic calcification	3	198	1.11	0.0346	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000498881	RB1,WRN,ERCC5
Monarch	HP:0000813	Bicornuate uterus	2	49	1.54	0.0348	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0003220	Abnormality of chromosome stability	2	49	1.54	0.0348	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0011356	Regional abnormality of skin	4	441	0.89	0.0348	9606.ENSP00000343741,9606.ENSP00000364699,9606.ENSP00000489597,9606.ENSP00000498881	ATR,SDHD,PTPN11,ERCC5
Monarch	HP:0100649	Neoplasm of the oral cavity	2	49	1.54	0.0348	9606.ENSP00000233146,9606.ENSP00000298139	MSH2,WRN
Monarch	HP:0001388	Joint laxity	3	200	1.11	0.0352	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000428056	ARID1A,SMARCA4,PIK3R1
Monarch	HP:0002061	Lower limb spasticity	3	200	1.11	0.0352	9606.ENSP00000254108,9606.ENSP00000362441,9606.ENSP00000364699	FUS,ATRX,SDHD
Monarch	HP:0009237	Short 5th finger	2	50	1.53	0.0358	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0000615	Abnormal pupil morphology	2	51	1.53	0.0370	9606.ENSP00000267163,9606.ENSP00000428056	RB1,PIK3R1
Monarch	HP:0003072	Hypercalcemia	2	51	1.53	0.0370	9606.ENSP00000228872,9606.ENSP00000364699	CDKN1B,SDHD
Monarch	HP:0004415	Pulmonary artery stenosis	2	51	1.53	0.0370	9606.ENSP00000298139,9606.ENSP00000489597	WRN,PTPN11
Monarch	HP:0009553	Abnormality of the hairline	3	205	1.1	0.0373	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000489597	ARID1A,SMARCA4,PTPN11
Monarch	HP:0011025	Abnormal cardiovascular system physiology	6	1169	0.64	0.0392	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000489597	MSH2,RB1,WRN,SMARCA4,SDHD,PTPN11
Monarch	EFO:0004747	Protein measurement	14	5856	0.31	0.0403	9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881	RSPO2,NTRK2,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ROS1,AR,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5
Monarch	HP:0000431	Wide nasal bridge	4	463	0.87	0.0404	9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	ATRX,PIK3R1,PTPN11,ERCC5
Monarch	HP:0000750	Delayed speech and language development	5	790	0.73	0.0405	9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000428056	NTRK2,ARID1A,SMARCA4,SDHD,PIK3R1
Monarch	HP:0003022	Hypoplasia of the ulna	2	54	1.5	0.0405	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0100026	Arteriovenous malformation	2	54	1.5	0.0405	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0000520	Proptosis	3	215	1.08	0.0417	9606.ENSP00000267430,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,BRCA2,PTPN11
Monarch	HP:0002827	Hip dislocation	3	215	1.08	0.0417	9606.ENSP00000267430,9606.ENSP00000343741,9606.ENSP00000369497	FANCM,ATR,BRCA2
Monarch	HP:0100585	Telangiectasia of the skin	2	55	1.49	0.0417	9606.ENSP00000298139,9606.ENSP00000498881	WRN,ERCC5
Monarch	HP:0002245	Meckel diverticulum	2	56	1.49	0.0429	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0001320	Cerebellar vermis hypoplasia	3	218	1.07	0.0432	9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896	ARID1A,ATR,SMARCA4
Monarch	HP:0002463	Language impairment	5	809	0.72	0.0442	9606.ENSP00000277120,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000428056	NTRK2,ARID1A,SMARCA4,SDHD,PIK3R1
Monarch	HP:0002860	Squamous cell carcinoma	2	57	1.48	0.0442	9606.ENSP00000298139,9606.ENSP00000498881	WRN,ERCC5
Monarch	HP:0005344	Abnormal carotid artery morphology	2	57	1.48	0.0442	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
Monarch	HP:0011389	Functional abnormality of the inner ear	5	812	0.72	0.0446	9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	ATRX,SDHD,PIK3R1,PTPN11,ERCC5
Monarch	HP:0001260	Dysarthria	4	480	0.85	0.0448	9606.ENSP00000233146,9606.ENSP00000363822,9606.ENSP00000489597,9606.ENSP00000498881	MSH2,AR,PTPN11,ERCC5
Monarch	HP:0000855	Insulin resistance	2	58	1.47	0.0451	9606.ENSP00000298139,9606.ENSP00000428056	WRN,PIK3R1
Monarch	HP:0001838	Rocker bottom foot	2	58	1.47	0.0451	9606.ENSP00000298139,9606.ENSP00000498881	WRN,ERCC5
Monarch	HP:0025668	Abnormal neck morphology	4	481	0.85	0.0451	9606.ENSP00000254108,9606.ENSP00000362441,9606.ENSP00000489597,9606.ENSP00000498881	FUS,ATRX,PTPN11,ERCC5
Monarch	HP:0003202	Skeletal muscle atrophy	4	483	0.85	0.0455	9606.ENSP00000254108,9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000364699	FUS,WRN,AR,SDHD
Monarch	EFO:0004315	Drinking behavior	3	225	1.06	0.0461	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000489597	ARID1A,SMARCA4,PTPN11
Monarch	HP:0000140	Abnormality of the menstrual cycle	3	228	1.05	0.0475	9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000489597	WRN,AR,PTPN11
Monarch	HP:0000444	Convex nasal ridge	2	60	1.46	0.0475	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
Monarch	HP:0001537	Umbilical hernia	3	228	1.05	0.0475	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497	FANCM,ATRX,BRCA2
Monarch	HP:0002981	Abnormality of the calf	3	229	1.05	0.0475	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441	RB1,ATR,ATRX
Monarch	HP:0005150	Abnormal atrioventricular conduction	2	60	1.46	0.0475	9606.ENSP00000364699,9606.ENSP00000489597	SDHD,PTPN11
Monarch	HP:0006753	Neoplasm of the stomach	2	60	1.46	0.0475	9606.ENSP00000233146,9606.ENSP00000500891	MSH2,MUTYH
Monarch	HP:0009879	Simplified gyral pattern	2	60	1.46	0.0475	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
Monarch	HP:0001482	Subcutaneous nodule	2	61	1.45	0.0481	9606.ENSP00000364699,9606.ENSP00000489597	SDHD,PTPN11
Monarch	HP:0002516	Increased intracranial pressure	2	61	1.45	0.0481	9606.ENSP00000233146,9606.ENSP00000364699	MSH2,SDHD
Monarch	HP:0011442	Abnormal central motor function	7	1689	0.55	0.0483	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000498881	MSH2,FUS,NTRK2,ATRX,AR,SDHD,ERCC5
Monarch	HP:0000479	Abnormal retinal morphology	5	836	0.71	0.0485	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000364699,9606.ENSP00000498881	RB1,NTRK2,WRN,SDHD,ERCC5
Monarch	EFO:0004574	Total cholesterol measurement	4	497	0.84	0.0487	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000489597	ARID1A,SMARCA4,BRCA2,PTPN11
Monarch	HP:0000122	Unilateral renal agenesis	2	62	1.44	0.0491	9606.ENSP00000342924,9606.ENSP00000489597	MCPH1,PTPN11
Monarch	HP:0011450	Unusual CNS infection	2	62	1.44	0.0491	9606.ENSP00000362441,9606.ENSP00000428056	ATRX,PIK3R1
Monarch	HP:0100886	Abnormality of globe location	5	839	0.71	0.0491	9606.ENSP00000267430,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	FANCM,ATRX,BRCA2,PIK3R1,PTPN11
DISEASES	DOID:14566	Disease of cellular proliferation	15	1101	1.07	2.62e-10	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,NTRK2,WRN,ARID1A,SMARCA4,ROS1,ATRX,AR,SDHD,BRCA2,PTPN11,MUTYH
DISEASES	DOID:0050686	Organ system cancer	13	757	1.17	7.45e-10	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	MSH2,FUS,RB1,NTRK2,WRN,ARID1A,SMARCA4,ROS1,ATRX,AR,SDHD,BRCA2,PTPN11
DISEASES	DOID:162	Cancer	14	978	1.09	7.45e-10	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,NTRK2,WRN,ARID1A,SMARCA4,ROS1,ATRX,AR,SDHD,BRCA2,PTPN11
DISEASES	DOID:225	Syndrome	14	1214	0.99	6.77e-09	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000276659,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,RSPO2,WRN,ARID1A,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
DISEASES	DOID:0050687	Cell type cancer	9	451	1.23	1.06e-06	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497	MSH2,FUS,RB1,ARID1A,SMARCA4,ROS1,ATRX,AR,BRCA2
DISEASES	DOID:1100	Ovarian disease	6	109	1.67	2.46e-06	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000369497	MSH2,FANCM,ARID1A,SMARCA4,AR,BRCA2
DISEASES	DOID:4	Disease	21	6291	0.46	3.19e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,SMARCA4,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
DISEASES	DOID:7	Disease of anatomical entity	19	4798	0.53	4.04e-06	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,SMARCA4,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,ERCC5,MUTYH
DISEASES	DOID:0050736	Autosomal dominant disease	12	1386	0.87	5.09e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000500891	CDKN1B,MSH2,FANCM,WRN,ARID1A,MCPH1,SMARCA4,SDHD,BRCA2,PIK3R1,PTPN11,MUTYH
DISEASES	DOID:0050177	Monogenic disease	16	3266	0.62	1.16e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FANCM,WRN,ARID1A,MCPH1,SMARCA4,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
DISEASES	DOID:0050739	Autosomal genetic disease	15	2802	0.66	1.33e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FANCM,WRN,ARID1A,MCPH1,SMARCA4,ATRX,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
DISEASES	DOID:193	Reproductive organ cancer	6	167	1.49	1.43e-05	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000369497	MSH2,WRN,ARID1A,SMARCA4,AR,BRCA2
DISEASES	DOID:305	Carcinoma	7	307	1.29	1.69e-05	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000369497	MSH2,RB1,ARID1A,SMARCA4,ROS1,AR,BRCA2
DISEASES	DOID:15	Reproductive system disease	7	317	1.28	1.94e-05	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000369497	MSH2,FANCM,WRN,ARID1A,SMARCA4,AR,BRCA2
DISEASES	DOID:28	Endocrine system disease	7	398	1.18	6.89e-05	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497	MSH2,FANCM,ARID1A,SMARCA4,AR,SDHD,BRCA2
DISEASES	DOID:299	Adenocarcinoma	5	119	1.56	6.89e-05	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000369497	RB1,ARID1A,ROS1,AR,BRCA2
DISEASES	DOID:2394	Ovarian cancer	4	55	1.79	0.00014	9606.ENSP00000233146,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497	MSH2,ARID1A,SMARCA4,BRCA2
DISEASES	DOID:1324	Lung cancer	4	64	1.73	0.00024	9606.ENSP00000267163,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000369497	RB1,SMARCA4,ROS1,BRCA2
DISEASES	DOID:3119	Gastrointestinal system cancer	5	161	1.42	0.00024	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000364699,9606.ENSP00000369497	MSH2,RB1,ARID1A,SDHD,BRCA2
DISEASES	DOID:3883	Lynch syndrome	3	15	2.23	0.00024	9606.ENSP00000233146,9606.ENSP00000369497,9606.ENSP00000500891	MSH2,BRCA2,MUTYH
DISEASES	DOID:4001	Ovarian carcinoma	3	16	2.21	0.00025	9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497	ARID1A,SMARCA4,BRCA2
DISEASES	DOID:0060072	Benign neoplasm	5	257	1.22	0.0017	9606.ENSP00000233146,9606.ENSP00000320485,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000500891	MSH2,ARID1A,ATRX,SDHD,MUTYH
DISEASES	DOID:0110030	Alpha thalassemia-X-linked intellectual disability syndrome	2	3	2.76	0.0020	9606.ENSP00000343896,9606.ENSP00000362441	SMARCA4,ATRX
DISEASES	DOID:4947	Cholangiocarcinoma	3	40	1.81	0.0025	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000369497	RB1,ARID1A,BRCA2
DISEASES	DOID:2355	Anemia	4	156	1.34	0.0042	9606.ENSP00000267430,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497	FANCM,SMARCA4,ATRX,BRCA2
DISEASES	DOID:10283	Prostate cancer	3	52	1.69	0.0043	9606.ENSP00000298139,9606.ENSP00000363822,9606.ENSP00000369497	WRN,AR,BRCA2
DISEASES	DOID:77	Gastrointestinal system disease	6	576	0.95	0.0050	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000500891	MSH2,RB1,ARID1A,SDHD,BRCA2,MUTYH
DISEASES	DOID:0060084	Cell type benign neoplasm	4	173	1.3	0.0056	9606.ENSP00000320485,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000500891	ARID1A,ATRX,SDHD,MUTYH
DISEASES	DOID:3713	Ovary adenocarcinoma	2	8	2.33	0.0064	9606.ENSP00000320485,9606.ENSP00000369497	ARID1A,BRCA2
DISEASES	DOID:0050424	Familial adenomatous polyposis	2	10	2.23	0.0089	9606.ENSP00000233146,9606.ENSP00000500891	MSH2,MUTYH
DISEASES	DOID:0110849	Xeroderma pigmentosum group G	2	10	2.23	0.0089	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
DISEASES	DOID:0050737	Autosomal recessive disease	9	1785	0.64	0.0097	9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,WRN,MCPH1,SMARCA4,ATRX,BRCA2,BIVM-ERCC5,ERCC5,MUTYH
DISEASES	DOID:3125	Multiple endocrine neoplasia	2	11	2.19	0.0097	9606.ENSP00000228872,9606.ENSP00000364699	CDKN1B,SDHD
DISEASES	DOID:201	Connective tissue cancer	3	82	1.5	0.0114	9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000362441	FUS,NTRK2,ATRX
DISEASES	DOID:0060085	Organ system benign neoplasm	4	237	1.16	0.0137	9606.ENSP00000233146,9606.ENSP00000362441,9606.ENSP00000364699,9606.ENSP00000500891	MSH2,ATRX,SDHD,MUTYH
DISEASES	DOID:3996	Urinary system cancer	3	89	1.46	0.0137	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896	RB1,ARID1A,SMARCA4
DISEASES	DOID:74	Hematopoietic system disease	5	473	0.96	0.0158	9606.ENSP00000267430,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000489597	FANCM,SMARCA4,ATRX,BRCA2,PTPN11
DISEASES	DOID:1925	Coffin-Siris syndrome	2	16	2.03	0.0159	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
DISEASES	DOID:9942	Lymph node disease	2	16	2.03	0.0159	9606.ENSP00000363822,9606.ENSP00000364699	AR,SDHD
DISEASES	DOID:65	Connective tissue disease	6	774	0.82	0.0163	9606.ENSP00000254108,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000489597	FUS,RSPO2,NTRK2,WRN,ATRX,PTPN11
DISEASES	DOID:13636	Fanconi anemia	2	25	1.84	0.0322	9606.ENSP00000267430,9606.ENSP00000369497	FANCM,BRCA2
DISEASES	DOID:3093	Nervous system cancer	3	130	1.3	0.0340	9606.ENSP00000267163,9606.ENSP00000343896,9606.ENSP00000362441	RB1,SMARCA4,ATRX
DISEASES	DOID:3908	Lung non-small cell carcinoma	2	26	1.82	0.0340	9606.ENSP00000357494,9606.ENSP00000369497	ROS1,BRCA2
TISSUES	BTO:0000744	Lymphocytic leukemia cell	9	419	1.26	1.27e-06	9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000428056,9606.ENSP00000489597	FUS,RB1,WRN,ARID1A,SMARCA4,TFEB,ATRX,PIK3R1,PTPN11
TISSUES	BTO:0001271	Leukemia cell	12	1067	0.98	1.27e-06	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	MSH2,FUS,RB1,WRN,ARID1A,ATR,SMARCA4,TFEB,ATRX,BRCA2,PIK3R1,PTPN11
TISSUES	BTO:0001541	Pronephros	7	219	1.44	3.01e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000369497	CDKN1B,MSH2,WRN,ARID1A,SMARCA4,ATRX,BRCA2
TISSUES	BTO:0000180	Cervical carcinoma cell	5	322	1.12	0.0151	9606.ENSP00000228872,9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000369497	CDKN1B,RB1,ATR,SMARCA4,BRCA2
TISSUES	BTO:0000583	Bone marrow cancer cell	5	442	0.99	0.0487	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000369497,9606.ENSP00000489597	RB1,ATR,SMARCA4,BRCA2,PTPN11
COMPARTMENTS	GOCC:0005654	Nucleoplasm	12	1146	0.95	2.70e-06	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497	CDKN1B,MSH2,FUS,RB1,FANCM,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,BRCA2
COMPARTMENTS	GOCC:0031981	Nuclear lumen	13	1850	0.78	2.43e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597	CDKN1B,MSH2,FUS,RB1,FANCM,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,BRCA2,PTPN11
COMPARTMENTS	GOCC:0005634	Nucleus	18	4787	0.51	6.25e-05	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
COMPARTMENTS	GOCC:0005694	Chromosome	9	951	0.91	0.00031	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497	RB1,FANCM,WRN,ARID1A,ATR,SMARCA4,ATRX,AR,BRCA2
COMPARTMENTS	GOCC:1990391	DNA repair complex	4	53	1.81	0.00031	9606.ENSP00000233146,9606.ENSP00000369497,9606.ENSP00000491742,9606.ENSP00000498881	MSH2,BRCA2,BIVM-ERCC5,ERCC5
COMPARTMENTS	GOCC:0016514	SWI/SNF complex	3	30	1.93	0.0019	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896	RB1,ARID1A,SMARCA4
COMPARTMENTS	GOCC:1904949	ATPase complex	4	120	1.46	0.0028	9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896	MSH2,RB1,ARID1A,SMARCA4
COMPARTMENTS	GOCC:0000785	Chromatin	6	476	1.03	0.0031	9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441,9606.ENSP00000363822	RB1,FANCM,ARID1A,SMARCA4,ATRX,AR
COMPARTMENTS	GOCC:0032991	Protein-containing complex	16	5325	0.41	0.0050	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881	CDKN1B,MSH2,RB1,FANCM,NTRK2,WRN,ARID1A,ATR,SMARCA4,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5
COMPARTMENTS	GOCC:0043227	Membrane-bounded organelle	20	9083	0.28	0.0106	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ATRX,AR,SDHD,BRCA2,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
COMPARTMENTS	GOCC:0043231	Intracellular membrane-bounded organelle	19	8162	0.3	0.0107	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ATRX,AR,SDHD,BRCA2,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
COMPARTMENTS	GOCC:0016604	Nuclear body	5	381	1.05	0.0108	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000363822	RB1,WRN,ATR,ATRX,AR
COMPARTMENTS	GOCC:1902494	Catalytic complex	9	1710	0.65	0.0108	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597	CDKN1B,MSH2,RB1,ARID1A,SMARCA4,SDHD,BRCA2,PIK3R1,PTPN11
COMPARTMENTS	GOCC:0000781	Chromosome, telomeric region	3	71	1.56	0.0115	9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497	WRN,ATRX,BRCA2
COMPARTMENTS	GOCC:0071942	XPC complex	2	10	2.23	0.0115	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
COMPARTMENTS	GOCC:0140092	bBAF complex	2	10	2.23	0.0115	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
COMPARTMENTS	GOCC:0016605	PML body	3	78	1.52	0.0128	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441	RB1,ATR,ATRX
COMPARTMENTS	GOCC:0071564	npBAF complex	2	13	2.12	0.0148	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
COMPARTMENTS	GOCC:0043229	Intracellular organelle	20	9609	0.25	0.0168	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ATRX,AR,SDHD,BRCA2,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
COMPARTMENTS	GOCC:0035060	Brahma complex	2	15	2.06	0.0175	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
COMPARTMENTS	GOCC:0071565	nBAF complex	2	15	2.06	0.0175	9606.ENSP00000320485,9606.ENSP00000343896	ARID1A,SMARCA4
COMPARTMENTS	GOCC:0110165	Cellular anatomical entity	23	14060	0.15	0.0354	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000276659,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,RSPO2,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
COMPARTMENTS	GOCC:0000228	Nuclear chromosome	4	320	1.03	0.0392	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000369497	RB1,ARID1A,SMARCA4,BRCA2
COMPARTMENTS	GOCC:0005622	Intracellular	21	11512	0.19	0.0483	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ATRX,AR,SDHD,BRCA2,PIK3R1,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
UniProt Keywords	KW-0234	DNA repair	8	325	1.32	1.61e-06	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000498881,9606.ENSP00000500891	MSH2,FANCM,WRN,ATR,ATRX,BRCA2,ERCC5,MUTYH
UniProt Keywords	KW-0238	DNA-binding	12	1971	0.72	0.00011	9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000498881	MSH2,FUS,RB1,FANCM,WRN,ARID1A,ATR,TFEB,ATRX,AR,BRCA2,ERCC5
UniProt Keywords	KW-0043	Tumor suppressor	5	177	1.38	0.00031	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000500891	CDKN1B,MSH2,RB1,BRCA2,MUTYH
UniProt Keywords	KW-0539	Nucleus	17	5278	0.44	0.00046	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000489597,9606.ENSP00000491742,9606.ENSP00000498881,9606.ENSP00000500891	CDKN1B,MSH2,FUS,RB1,FANCM,WRN,ARID1A,ATR,SMARCA4,TFEB,ATRX,AR,BRCA2,PTPN11,BIVM-ERCC5,ERCC5,MUTYH
UniProt Keywords	KW-0347	Helicase	4	141	1.39	0.0025	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000362441	FANCM,WRN,SMARCA4,ATRX
UniProt Keywords	KW-0832	Ubl conjugation	11	2399	0.59	0.0028	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056	CDKN1B,MSH2,FUS,NTRK2,WRN,SMARCA4,TFEB,ATRX,AR,BRCA2,PIK3R1
UniProt Keywords	KW-0597	Phosphoprotein	19	8122	0.3	0.0051	9606.ENSP00000228872,9606.ENSP00000233146,9606.ENSP00000254108,9606.ENSP00000267163,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000320485,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000351742,9606.ENSP00000357494,9606.ENSP00000362441,9606.ENSP00000363822,9606.ENSP00000369497,9606.ENSP00000428056,9606.ENSP00000489597,9606.ENSP00000498881	CDKN1B,MSH2,FUS,RB1,FANCM,NTRK2,WRN,ARID1A,MCPH1,ATR,SMARCA4,TFEB,ROS1,ATRX,AR,BRCA2,PIK3R1,PTPN11,ERCC5
UniProt Keywords	KW-0067	ATP-binding	8	1379	0.7	0.0083	9606.ENSP00000233146,9606.ENSP00000267430,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000343896,9606.ENSP00000357494,9606.ENSP00000362441	MSH2,FANCM,NTRK2,WRN,ATR,SMARCA4,ROS1,ATRX
UniProt Keywords	KW-0156	Chromatin regulator	4	292	1.07	0.0236	9606.ENSP00000267163,9606.ENSP00000320485,9606.ENSP00000343896,9606.ENSP00000362441	RB1,ARID1A,SMARCA4,ATRX
SMART	SM00487	DEAD-like helicases superfamily	4	103	1.52	0.0055	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000362441	FANCM,WRN,SMARCA4,ATRX
SMART	SM00490	Helicase superfamily c-terminal domain	4	107	1.51	0.0055	9606.ENSP00000267430,9606.ENSP00000298139,9606.ENSP00000343896,9606.ENSP00000362441	FANCM,WRN,SMARCA4,ATRX
SMART	SM00279	Helix-hairpin-helix class 2 (Pol1 family) motifs	2	5	2.53	0.0075	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
SMART	SM00484	Xeroderma pigmentosum G I-region	2	5	2.53	0.0075	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
SMART	SM00485	Xeroderma pigmentosum G N-region	2	5	2.53	0.0075	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
